BeyondSpring Announces Fourth Quarter and Year End 2020 Financial Results and Provides a Corporate Update


NDAs filed in
the
U.S. and China in
Mar. 2021
based on superior data from Phase 3 PROTECTIVE-2 trial of Breakthrough Therapy Designation regimen, plinabulin plus G-CSF vs. G-CSF alone in prevention of CIN

– Company subsidiary, SEED Therapeutics, signed an $800 million research collaboration with Eli Lilly leveraging its proprietary targeted protein degradation (TPD) platform in Nov. 2020

– Completed $86.3 million equity financing in Nov. 2020. Cash and cash equivalents of $109.5 million at year-end 2020

Company to host a conference call today, April 30 at 8:30 a.m. ET

NEW YORK, April 30, 2021 (GLOBE NEWSWIRE) — BeyondSpring Inc. (the “Company” or “BeyondSpring”) (NASDAQ: BYSI), a global biopharmaceutical company focused on the development of innovative cancer therapies, today announced its financial results for the fourth quarter and year ended December 31, 2020 and provided an update on recent corporate events.

“2020 was a truly transformational year in setting us up for future value creation. Specifically, we had key accomplishments in building clinical evidence for our lead asset, filing our lead program in two major global markets – US and China, building our pipeline, adding key scientific and business leadership, and bolstering our balance sheet to execute on our vision,” said Dr. Lan Huang, co-founder, chairwoman and chief executive officer of BeyondSpring.

“The Company is well positioned for the future, with our “pipeline in a drug” plinabulin, and anticipated near-term potential anti-cancer efficacy data from a Phase 3 trial measuring overall survival in NSCLC, and from early trials in several immuno-oncology regimens in checkpoint inhibitor naïve or failed patients,” continued Dr. Huang. “After the successful completion of our equity financing in the fourth quarter, we have strengthened our balance sheet and cash position as we head into our upcoming milestones.”


Recent Business and Corporate Highlights

Lead Asset Plinabulin, a “Pipeline in a Drug”

Recent Clinical Update

  • March 2021: filed NDAs with the U.S. Food and Drug Administration (FDA) and China NMPA for the use of plinabulin in combination with granulocyte colony-stimulating factor (G-CSF) for the prevention of chemotherapy-induced neutropenia (CIN). Plinabulin and G-CSF combination regimen had received breakthrough designation from both US FDA and China NMPA.
  • December 2020: completed global enrollment of 559 patients in DUBLIN-3 Phase 3 non-small cell lung cancer (NSCLC) study, comparing plinabulin + docetaxel vs. docetaxel alone in 2nd/3rd line NSCLC (EGFR wild type), with overall survival as the primary endpoint.
  • November 2020: announced positive and superior topline results from its Phase 3 PROTECTIVE-2 registrational trial of plinabulin in combination with pegfilgrastim vs. pegfilgrastim alone for the prevention of CIN, with additional positive Phase 3 data presented at the 2020 San Antonio Breast Cancer Symposium.

Upcoming Clinical Milestones

  • June 2021 (ASCO presentation): Phase 1 IO combo data of plinabulin + PD-1 + CTLA-4 inhibitors for recurrent Small Cell Lung Cancer (SCLC) in checkpoint inhibitor naïve and failed patients.
  • Mid-2021 (DUBLIN-3): topline overall survival (OS) data expected in pivotal Phase 3 NSCLC study.
  • 2H 2022 (MD Anderson investigator led study): Phase 1 Data expected in plinabulin + PD-1/PD-L1 inhibitors + radiation in PD-1/PD-L1-failed patients in seven cancers, including Bladder Cancer, Melanoma, Merkel Cell Cancer, MSI-H Cancers (of any histology), Non-small Cell Lung Cancer, Renal Cell Cancer, and Small Cell Lung Cancer.

Seed Therapeutics Proprietary “Molecular Glue” TPD platform

  • November 2020: announced SEED subsidiary’s $800 million R&D collaboration with Eli Lilly based on SEED’s proprietary “molecular glue” TPD platform.

Recent Corporate Highlights

  • December 2020: Strengthened the Board of Directors with the appointment of Jeffrey Vacirca, M.D., FACP. Dr. Vacirca is a board-certified hematologist and oncologist and serves as CEO and Chairman of the Board of New York Cancer & Blood Specialists and holds several other significant leadership positions in the oncology community.

  • November 2020: Completed a financing of approximately $86.3 million in gross proceeds, before deducting underwriting discounts and commissions and other offering expenses. Total cash and cash equivalents as of December 31, 2020 was $109.5 million.


Fourth Quarter 2020 Financial Results

Research and development (“R&D”) expenses were $8.4 million for the quarter ended December 31, 2020, compared to $12.6 million for the quarter ended December 31, 2019. The decrease of $4.2 million was primarily due to a decrease in pre-clinical and clinical trial expenses.  

General and administrative (“G&A”) expenses were $10.4 million for the quarter ended December 31, 2020, compared to $2.7 million for the quarter ended December 31, 2019. The $7.7 million increase was primarily due to an increase of $3.0 million in personnel costs, including new hires and certain one-time incentive payments, an increase of $2.6 million in pre-commercialization costs, an increase of $1.8 million in non-cash share-based compensation, and an increase in legal and other costs related to the SEED subsidiary. 

Net loss attributable to the Company was $17.6 million for the quarter ended December 31, 2020, compared to $14.1 million for the quarter ended December 31, 2019.


Full Year 2020 Financial Results

Research and development (“R&D”) expenses were $41.8 million for the year ended December 31, 2020, compared to $31.3 million for the year ended December 31, 2019. The $10.5 million increase was largely due to an increase of $3.8 million in clinical trial expenses, an increase of $3.5 million in non-cash share-based compensation and an increase of $2.7 million mainly due to amounts paid to consultants and others to support the NDA filing.

General and administrative (“G&A”) expenses were $22.6 million for the year ended December 31, 2020, compared to $9.0 million for the year ended December 31, 2019. The $13.6 million increase was primarily due to an increase of $5.6 million related to pre-commercialization costs, an increase of $4.5 million in salaries and benefits for commercial and executive personnel, including certain one-time incentive payments, an increase of $2.6 million in non-cash share-based compensation expense, and an increase of $0.9 million in professional services and other expenses. 

Net loss attributable to the Company was $61.0 million for the year ended December 31, 2020, compared to $38.1 million for the year ended December 31, 2019.  

As of December 31, 2020, the Company had cash and cash equivalents of $109.5 million on hand. The Company believes it has sufficient cash to support its ongoing clinical programs over the next year, including its immuno-oncology pipeline, and to prepare for a potential launch of plinabulin in 2022.

Fourth Quarter and Full Year 2020 Results Conference Call and Webcast Details

The management of BeyondSpring will host a conference call and webcast for the investment community today, April 30, 2021, at 8:30 am ET. The conference call can be accessed by dialing 855-327-6837 (U.S. and Canada) or +1-631-891-4304 (International). The passcode for the conference call is 10014535 To access the live webcast or subsequent archived recording, click here or visit the “investors” section of the BeyondSpring website at www.beyondspringpharma.com. The webcast will be recorded and available for replay on the company’s website for 90 days.

About BeyondSpring

Headquartered in New York City, BeyondSpring is a global biopharmaceutical company focused on developing innovative cancer therapies to improve clinical outcomes for patients who have high unmet medical needs. BeyondSpring’s first-in-class lead asset, plinabulin, a SelectiveImmunomodulating Microtubule-Binding Agent (SIMBA) is being developed as a “pipeline in a drug.” It is filed for approval in the U.S. and China for the prevention of chemotherapy-induced neutropenia (CIN) and has a fully enrolled pivotal study to test an anti-cancer benefit with an overall survival primary endpoint in non-small cell lung cancer (NSCLC). Additionally, it is being broadly studied in combination with various immuno-oncology regimens that could boost the effects of PD-1 / PD-L1 antibodies. In addition to plinabulin, BeyondSpring’s extensive pipeline includes three pre-clinical immuno-oncology assets and a subsidiary, SEED Therapeutics, which is leveraging a proprietary targeted protein degradation drug discovery platform (TPD).

Cautionary Note Regarding Forward-Looking Statements

This press release includes forward-looking statements that are not historical facts. Words such as “will,” “expect,” “anticipate,” “plan,” “believe,” “design,” “may,” “future,” “estimate,” “predict,” “objective,” “goal,” or variations thereof and variations of such words and similar expressions are intended to identify such forward-looking statements. Forward-looking statements are based on BeyondSpring’s current knowledge and its present beliefs and expectations regarding possible future events and are subject to risks, uncertainties and assumptions. Actual results and the timing of events could differ materially from those anticipated in these forward-looking statements as a result of several factors including, but not limited to, difficulties raising the anticipated amount needed to finance the Company’s future operations on terms acceptable to the Company, if at all, unexpected results of clinical trials, delays or denial in regulatory approval process, results that do not meet our expectations regarding the potential safety, the ultimate efficacy or clinical utility of our product candidates, increased competition in the market, and other risks described in BeyondSpring’s most recent Form 20-F on file with the U.S. Securities and Exchange Commission. All forward-looking statements made herein speak only as of the date of this release and BeyondSpring undertakes no obligation to update publicly such forward-looking statements to reflect subsequent events or circumstances, except as otherwise required by law.

Investor Contact:

Ashley R. Robinson
LifeSci Advisors, LLC
+1 617-430-7577
[email protected]

Media Contact:

Darren Opland, Ph.D.
LifeSci Communications
+1 646-627-8387
[email protected]

BEYONDSPRING INC.

CONSOLIDATED BALANCE SHEETS

(Amounts in thousands of U.S. Dollars (“$”), except for number of shares and per share data)

  As of December 31,
  2019 2020
  $ $
     
Assets    
Current assets:    
Cash and cash equivalents 35,933 109,537
Advances to suppliers 4,519 3,505
Prepaid expenses and other current assets 410 358
Total current assets 40,862 113,400
     
Noncurrent assets:    
Property and equipment, net 209 184
Operating lease right-of-use assets 2,538 2,174
Other noncurrent assets 946 1,280
Total noncurrent assets 3,693 3,638
     
Total assets 44,555 117,038
     
Liabilities and equity    
     
Current liabilities:    
Accounts payable 2,537 2,216
Accrued expenses 5,861 5,607
Due to related parties 29
Current portion of operating lease liabilities 537 787
Deferred revenue 1,350
Other current liabilities 1,089 3,806
Total current liabilities 10,053 13,766
     
Noncurrent liabilities:    
Long-term loans 1,436 2,167
Operating lease liabilities 1,935 1,359
Deferred revenue 7,925
Total noncurrent liabilities 3,371 11,451
     
Total liabilities 13,424 25,217
     
Commitments and contingencies      

                                

BEYONDSPRING INC.

CONSOLIDATED BALANCE SHEETS (Continued)

(Amounts in thousands of U.S. Dollars (“$”), except for number of shares and per share data)

  As of December 31,
  2019     2020  
  $     $  
           
Mezzanine Equity          
Contingently redeemable noncontrolling interests     5,196  
           
Equity          
Ordinary shares ($0.0001 par value; 500,000,000 shares authorized; 27,885,613 and 39,141,913 shares issued and outstanding as of December 31, 2019 and 2020, respectively) 3     4  
Additional paid-in capital 246,979     366,451  
Accumulated deficit (216,845 )   (277,818 )
Accumulated other comprehensive income (loss) 140     (297 )
           
Total BeyondSpring Inc.’s shareholders’ equity 30,277     88,340  
Noncontrolling interests 854     (1,715 )
Total equity 31,131     86,625  
           
Total liabilities, mezzanine equity and equity 44,555     117,038  
           



BEYONDSPRING INC.

CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS

(Amounts in thousands of U.S. Dollars (“$”), except for number of shares and per share data)

  Year ended December 31,
  2018     2019     2020  
  $     $     $  
Revenue                          180  
                 
Operating expenses                
Research and development (51,618 )   (31,342 )   (41,793 )
General and administrative (5,927 )   (8,965 )   (22,598 )
                 
Loss from operations (57,545 )   (40,307 )   (64,211 )
Foreign exchange (loss) gain, net (455 )   (4 )   355  
Interest expense     (206 )   (85 )
Interest income 211     184     116  
Other income 315         4  
                 
Loss before income tax (57,474 )   (40,333 )   (63,821 )
Income tax benefit          
                 
Net loss (57,474 )   (40,333 )   (63,821 )
Less: Net loss attributable to noncontrolling interests (2,605 )   (2,248 )   (2,848 )
Net loss attributable to BeyondSpring Inc. (54,869 )   (38,085 )   (60,973 )
                 
Net loss per share                
Basic and diluted (2.42 )   (1.55 )   (2.03 )
Weighted average shares outstanding                
Basic and diluted 22,665,265     24,645,714     29,984,284  
                 
Other comprehensive loss, net of tax of nil:                
Foreign currency translation adjustment gain (loss) 251     96     (530 )
Comprehensive loss (57,223 )   (40,237 )   (64,351 )
Less: Comprehensive loss attributable to noncontrolling interests (2,578 )   (2,250 )   (2,941 )
Comprehensive loss attributable to BeyondSpring Inc. (54,645 )   (37,987 )   (61,410 )

 



Holley Appoints Consumer Retail Executive as Chief Financial Officer

Holley Appoints Consumer Retail Executive as Chief Financial Officer

BOWLING GREEN, Ky.–(BUSINESS WIRE)–
Holley, the largest and fastest growing platform for performance automotive enthusiasts, today announced that Dominic Bardos has been appointed Chief Financial Officer. A seasoned financial executive with extensive public company experience, Mr. Bardos will serve as a member of the executive leadership team and report directly to President and Chief Executive Officer Tom Tomlinson.

“I am pleased to welcome Dominic Bardos as our CFO,” said Tomlinson. “Dominic brings over 30 years of global finance and accounting experience across multiple industries, including retail, consumer services, entertainment, and hospitality. He has a proven track record of delivering results and creating value. Dominic’s public company experience along with his expertise in providing insightful and actionable business analysis and his focus on leading and developing high-performing teams will play a vital role in supporting our success as a public company.”

Most recently, Mr. Bardos served as Vice President of Finance for Tractor Supply Company, the largest publicly traded rural lifestyle retailer. Previously, he served as Chief Financial Officer for Cambridge Franchise Holdings. Additionally, he held several leadership positions at ServiceMaster including three years as the divisional CFO for Terminix, their largest division. His experience also includes leadership positions in financial planning & analysis, strategic sourcing, supply chain, and customer service operations in large organizations such as Caesars Entertainment, Hilton Hotels, and Harrah’s Entertainment.

“I am thrilled to be joining Holley at such an exciting time in the company’s history and to have the opportunity to further elevate this brand that so many performance car and truck enthusiasts love. Those valuable consumer relationships and Holley’s long track record of innovation puts the company on a strong road to achieving growth, and I look forward to helping drive Holley on its journey,” said Bardos.

Dominic earned a Master of Business Administration in Finance and a Bachelor’s degree in Management from the University of Memphis, Fogelman College of Business & Economics.

The appointment comes after Holley recently entered into an agreement to become a public company through a business combination with Empower Ltd. (NYSE: EMPW, EMPW-UN, EMPW-WT), a publicly traded special purpose acquisition company. Holley’s majority shareholder is Sentinel Capital Partners, L.L.C., one of the nation’s leading midmarket private equity firms.

About Holley

Holley is a leading designer, marketer, and manufacturer of high-performance products for car and truck enthusiasts. Holley offers the largest portfolio of iconic brands that deliver innovation and inspiration to a large and diverse community of millions of avid automotive enthusiasts who are passionate about the performance and personalization of their classic and modern cars. Holley has disrupted the performance category by putting the enthusiast consumer first, developing innovative new products, and building a robust M&A process that has added meaningful scale and diversity to its platform. For more information on Holley, visit www.holley.com.

About Empower, Ltd.

Empower is a blank check company formed by MidOcean Partners whose business purpose is to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. Empower’s management team is led by Mr. Rubel, its Chief Executive Officer and Executive Chairman of its Board of Directors, and Mr. Clempson, Empower’s President. Empower raised $250,000,000 in its initial public offering in October 2020 and is listed on the NYSE under the ticker symbols “EMPW”, “EMPW-UN” and “EMPW-WT”. For more information, visit www.empowermidocean.com.

About Sentinel Capital Partners

Sentinel specializes in buying and building lower midmarket businesses in the United States and Canada in partnership with management. Sentinel targets business services, consumer, healthcare services, and industrial businesses. Sentinel invests in management buyouts, recapitalizations, corporate divestitures, going-private transactions, and structured equity investments of established businesses with EBITDA of up to $80 million. Sentinel also invests in special situations, including balance sheet restructurings and operational turnarounds. For more information about Sentinel, visit www.sentinelpartners.com.

Media:

Phil Denning / Michael Wolfe

ICR, Inc.

[email protected]

(646) 277-1200

KEYWORDS: United States North America Kentucky

INDUSTRY KEYWORDS: Finance Automotive General Automotive Banking Automotive Manufacturing Professional Services Manufacturing Other Automotive Performance & Special Interest

MEDIA:

IRADIMED CORPORATION Announces First Quarter 2021 Financial Results

  • Reports first quarter 2021 revenue of $9.2 million, GAAP diluted EPS of $0.11 and non-GAAP diluted EPS of $0.13
  • Reports combined cash and investments of $52.7 million as of March 31, 2021

WINTER SPRINGS, Fla., April 30, 2021 (GLOBE NEWSWIRE) — IRADIMED CORPORATION (the “Company”) (NASDAQ: IRMD), a leader in the development of innovative magnetic resonance imaging (“MRI”) medical devices and the only known provider of a non-magnetic intravenous (“IV”) infusion pump system, and non-magnetic patient vital signs monitoring systems that are designed for use during MRI procedures, today announced financial results for the three months ended March 31, 2021.

“First quarter bookings and revenue exceeded our internal expectations as we continue gaining greater access to our U.S. customers. Additionally, we were able to grow IV pump revenue nearly 32 percent over last year. Especially noteworthy is the 112 percent increase in income before taxes, indicating the true strength of this quarter. EPS was, by comparison, down due to tax benefits we harvested last year. Business strength was further validated by our ability to grow backlog from its already elevated levels at the end of last year. Overall, Iradimed has delivered a very good start to the year and I am very pleased with these results,” said Roger Susi, President and Chief Executive Officer of the Company.

For the first quarter ended March 31, 2021, the Company reported revenue of $9.2 million compared to $8.7 million for the first quarter 2020. Net income was $1.4 million, or $0.11 per diluted share, compared to $1.8 million, or $0.14 per diluted share for the first quarter 2020. The decrease in net income and diluted earnings per share is primarily the result of the recognition of $0.4 million of tax expense during the first quarter 2021, compared to a tax benefit of $(0.9) million recognized during the first quarter 2020.

Non-GAAP net income was $1.6 million for the quarter ended March 31, 2021, which excludes $0.3 million of stock compensation expense, net of tax expense. Non-GAAP net income for the quarter ended March 31, 2020 was $2.2 million, which excludes $0.4 million of stock compensation expense, net of tax expense. Non-GAAP earnings per diluted share was $0.13 for the first quarter 2021, compared to $0.18 for the first quarter 2020.

Revenue Information:

  Three Months Ended

March 31,
  2021   2020
Devices:      
MRI compatible IV infusion pump system $ 3,503,347   $ 2,664,834
MRI compatible patient vital signs monitoring systems 2,603,830   2,888,703
Total Devices revenue 6,107,177   5,553,537
Disposables, services and other 2,635,466   2,662,713
Amortization of extended warranty agreements 481,353   461,291
Total revenue $ 9,223,996   $ 8,677,541

Domestic sales were 78.8 percent of total revenue, compared to 72.9 percent for the first quarter 2020. Gross profit margin was 76.6 percent for the first quarter 2021, compared to 74.5 percent for the first quarter 2020.

Cash Flow and Balance Sheet:

For the three months ended March 31, 2021, cash from operations was $0.9 million, compared to $1.2 million for the same period in 2020.

For the first quarter ended March 31, 2021, free cash flow was $0.8 million, compared to $1.0 million for the first quarter 2020.

As of March 31, 2021, the Company had combined cash and investments of $52.7 million.

Financial Guidance

Significant uncertainty remains regarding the impact of COVID-19 on the Company’s financial results. Accordingly, the Company believes it is prudent to refrain from providing financial guidance at this time. The Company continues to monitor the circumstances around the pandemic and will provide financial guidance once there is more certainty around the pandemic’s impact on its business.

Use of non-GAAP Financial Measures

The Company believes the use of non-GAAP net income, free cash flow and infrequent income tax items are helpful to our investors. These measures, which we refer to as our non-GAAP financial measures, are not prepared in accordance with U.S. GAAP.

We calculate non-GAAP net income as net income excluding (1) stock-based compensation expense, net of tax. Because of varying available valuation methodologies, subjective assumptions and the variety of equity instruments that can impact a company’s non-cash expenses, we believe that providing non-GAAP financial measures that exclude stock-based compensation expense allows for meaningful comparisons between our operating results from period to period; (2) operating expenses, net of tax, that we believe are not indicative of the Company’s on-going core operating performance, and; (3) infrequent tax items are considered based on their nature and are excluded from the provision for income taxes as these costs or benefits are not indicative of our normal or future provision for income taxes. We calculate free cash flow as net cash provided by operating activities, less net cash used in investing activities for purchases of property and equipment.

We consider free cash flow to be a liquidity measure that provides useful information to management and investors about the amount of cash generated by our business that can be used for strategic opportunities, including investing in our business, making strategic acquisitions, strengthening our balance sheet and returning cash to our shareholders via share repurchases.

All of our non-GAAP financial measures are important tools for financial and operational decision making and for evaluating our on-going core operating results.

A reconciliation of the non-GAAP financial measures used in this release to the most comparable U.S. GAAP measures for the respective periods can be found in the table later in this release immediately following the condensed statements of cash flows. These non-GAAP financial measures should not be considered in isolation or as a substitute for a measure of the Company’s operating performance or liquidity prepared in accordance with U.S. GAAP and are not indicative of net income or cash provided by operating activities.

Conference Call

iRadimed has scheduled a conference call to discuss this announcement beginning at 11:00 a.m. Eastern Time today, April 30, 2021. Individuals interested in listening to the conference call may do so by dialing 1-844-413-1781 for domestic callers, or 1-716-247-5767 for international callers, and entering the reservation code 8386999.

The conference call will also be available real-time via the internet at http://www.iradimed.com/en-us/investors/events/. A recording of the call will be available on the Company’s website following the completion of the call.

About IRADIMED CORPORATION

IRADIMED CORPORATION is a leader in the development of innovative magnetic resonance imaging (“MRI”) compatible medical devices. We are the only known provider of a non-magnetic intravenous (“IV”) infusion pump system that is specifically designed to be safe for use during MRI procedures. We were the first to develop an infusion delivery system that largely eliminates many of the dangers and problems present during MRI procedures. Standard infusion pumps contain magnetic and electronic components which can create radio frequency interference and are dangerous to operate in the presence of the powerful magnet that drives an MRI system. Our patented MRidium® MRI compatible IV infusion pump system has been designed with a non-magnetic ultrasonic motor, uniquely designed non-ferrous parts and other special features to safely and predictably deliver anesthesia and other IV fluids during various MRI procedures. Our pump solution provides a seamless approach that enables accurate, safe and dependable fluid delivery before, during and after an MRI scan, which is important to critically-ill patients who cannot be removed from their vital medications, and children and infants who must generally be sedated to remain immobile during an MRI scan.

Our 3880 MRI compatible patient vital signs monitoring system has been designed with non-magnetic components and other special features to safely and accurately monitor a patient’s vital signs during various MRI procedures. The IRADIMED 3880 system operates dependably in magnetic fields up to 30,000 gauss, which means it can operate virtually anywhere in the MRI scanner room. The IRADIMED 3880 has a compact, lightweight design allowing it to travel with the patient from their critical care unit, to the MRI and back, resulting in increased patient safety through uninterrupted vital signs monitoring and decreasing the amount of time critically ill patients are away from critical care units. The features of the IRADIMED 3880 include: wireless ECG with dynamic gradient filtering; wireless SpO2 using Masimo® algorithms; non-magnetic respiratory CO2; invasive and non-invasive blood pressure; patient temperature, and; optional advanced multi-gas anesthetic agent unit featuring continuous Minimum Alveolar Concentration measurements. The IRADIMED 3880 MRI compatible patient vital signs monitoring system has an easy-to-use design and allows for the effective communication of patient vital signs information to clinicians.

For more information please visit www.iradimed.com.  

Forward-Looking Statements

This press release contains forward-looking statements as defined in the Private Securities Litigation Act of 1995, particularly statements regarding our expectations, beliefs, plans, intentions, future operations, financial condition and prospects, and business strategies. These statements relate to future events or our future financial performance or condition and involve unknown risks, uncertainties and other factors that could cause our actual results, level of activity, performance or achievement to differ materially from those expressed or implied by these forward-looking statements. The risks and uncertainties referred to above include, but are not limited to, risks associated with the Company’s ability to receive an EC Certificate or CE Mark for our existing products and product candidates, receive FDA 510(k) clearance for new products and product candidates; unexpected costs, delays or diversion of management’s attention associated with the design, manufacture or sale of new products; the Company’s ability to implement successful sales techniques for existing and future products and evaluate the effectiveness of its sales techniques; additional actions, warnings or requests from the FDA or other regulatory bodies; our significant reliance on a limited number of products; potential disruptions in our limited supply chain for our products; a reduction in international distribution; actions of the FDA or other regulatory bodies that could delay, limit or suspend product development, manufacturing or sales; the effect of recalls, patient adverse events or deaths on our business; difficulties or delays in the development, production, manufacturing and marketing of new or existing products and services; changes in laws and regulations or in the interpretation or application of laws or regulations.

Further information on these and other factors that could affect the Company’s financial results is included in filings we make with the Securities and Exchange Commission from time to time. All forward-looking statements are based on information available to us on the date hereof, and we assume no obligation to update forward-looking statements.

IRADIMED CORPORATION

CONDENSED BALANCE SHEETS

  March 31,

2021
  December 31,
2020
  (unaudited)    
ASSETS      
Current assets:      
Cash and cash equivalents $ 50,801,629   $ 50,068,728
Accounts receivable, net 4,564,172   4,574,932
Investments 1,902,940   1,909,368
Inventory, net 4,640,556   3,933,987
Prepaid expenses and other current assets 929,382   771,666
Prepaid income taxes 2,373,828   2,477,211
Total current assets 65,212,507   63,735,892
Property and equipment, net 2,126,079   2,120,148
Intangible assets, net 976,382   960,885
Operating lease right-of-use asset 2,652,533   2,715,030
Deferred income taxes, net 985,336   1,272,672
Other assets 236,089   261,993
Total assets $ 72,188,926   $ 71,066,620
LIABILITIES AND STOCKHOLDERS’ EQUITY      
Current liabilities:      
Accounts payable $ 618,217   $ 657,054
Accrued payroll and benefits 1,232,683   1,714,782
Other accrued taxes 77,593   103,981
Warranty reserve 96,448   90,054
Deferred revenue 2,203,589   1,949,259
Current portion of operating lease liability 259,553   255,698
Other current liabilities 146,435   146,435
Total current liabilities 4,634,518   4,917,263
Deferred revenue 2,083,342   2,305,413
Operating lease liability 2,392,980   2,459,332
Total liabilities 9,110,840   9,682,008
Stockholders’ equity:      
Common stock 1,231   1,231
Additional paid-in capital 23,988,337   23,676,843
Retained earnings 39,056,300   37,669,451
Accumulated other comprehensive income 32,218   37,087
Total stockholders’ equity 63,078,086   61,384,612
Total liabilities and stockholders’ equity $ 72,188,926   $ 71,066,620



IRADIMED CORPORATION

CONDENSED STATEMENTS OF OPERATIONS

(Unaudited)

  Three Months Ended

March 31,
 
  2021   2020  
Revenue $ 9,223,996   $ 8,677,541  
Cost of revenue 2,161,680   2,213,730  
Gross profit 7,062,316   6,463,811  
Operating expenses:        
General and administrative 2,430,369   2,862,727  
Sales and marketing 2,379,124   2,433,567  
Research and development 475,817   430,282  
Total operating expenses 5,285,310   5,726,576  
Income from operations 1,777,006   737,235  
Other (expense) income, net (5,663 ) 98,502  
Income before provision for income taxes 1,771,343   835,737  
Provision for income tax expense (benefit) 384,494   (933,474 )
Net income $ 1,386,849   $ 1,769,211  
         
Net income per share:        
Basic $ 0.11   $ 0.15  
Diluted $ 0.11   $ 0.14  
Weighted average shares outstanding:        
Basic 12,310,577   11,891,428  
Diluted 12,521,279   12,365,605  



IRADIMED CORPORATION

CONDENSED STATEMENTS OF CASH FLOWS

(Unaudited)

  Three Months Ended

March 31,
 
  2021     2020  
Operating activities:          
Net income $ 1,386,849     $ 1,769,211  
Adjustments to reconcile net income to net cash provided by operating activities:          
Change in allowance for doubtful accounts 1,728     36,756  
Change in provision for excess and obsolete inventory (1,992 )   128,143  
Depreciation and amortization 331,794     344,784  
Stock-based compensation 347,741     568,958  
Deferred income taxes, net 288,895     (32,472 )
Changes in operating assets and liabilities:          
Accounts receivable 9,032     1,404,704  
Inventory (668,361 )   (560,996 )
Prepaid expenses and other current assets (560,508 )   (538,093 )
Other assets 32,059     (60,614 )
Accounts payable (75,805 )   (266,644 )
Accrued payroll and benefits (482,099 )   (542,834 )
Other accrued taxes (26,388 )   (469,750 )
Warranty reserve 6,394     7,924  
Deferred revenue 250,359     308,559  
Prepaid income taxes 103,383     (901,001 )
Net cash provided by operating activities 943,081     1,196,635  
Investing activities:          
Purchases of property and equipment (132,318 )   (166,593 )
Capitalized intangible assets (41,615 )   (63,782 )
Net cash used in investing activities (173,933 )   (230,375 )
Financing activities:          
Proceeds from exercises of stock options 2,460     322,179  
Taxes paid related to net share settlement of equity awards (38,707 )   (133,872 )
Net cash (used in) provided by financing activities (36,247 )   188,307  
Net increase in cash and cash equivalents 732,901     1,154,567  
Cash and cash equivalents, beginning of period 50,068,728     43,481,781  
Cash and cash equivalents, end of period $ 50,801,629     $ 44,636,348  



IRADIMED CORPORATION

RECONCILIATION OF NON-GAAP FINANCIAL MEASURES (UNAUDITED)

Non-GAAP Net Income and Diluted EPS

  Three Months Ended

March 31,
  2021   2020
       
Net income $ 1,386,849   $ 1,769,211
Excluding:      
Stock-based compensation expense, net of tax expense 262,809   427,800
Non-GAAP net income $ 1,649,658   $ 2,197,011
Weighted-average shares outstanding – diluted 12,521,279   12,365,605
Non-GAAP net income per share – diluted $ 0.13   $ 0.18



Free Cash Flow

  Three Months Ended

March 31,
  2021   2020
Net cash provided by operating activities $ 943,081   $ 1,196,635
Less:      
Purchases of property and equipment 132,318   166,593
Free cash flow $ 810,763   $ 1,030,042

Media Contact:
Chris Scott
Chief Financial Officer
IRADIMED CORPORATION
(407) 677-8022
[email protected] 



Newell Brands Announces First Quarter 2021 Results

Newell Brands Announces First Quarter 2021 Results

Net Sales Growth 21.3%; Core Sales Growth 20.9%

Delivers Significant Operating Profit and Operating Margin Improvement

Diluted EPS $0.21; Normalized Diluted EPS $0.30

Raises Net Sales and EPS Outlook for 2021

ATLANTA–(BUSINESS WIRE)–
Newell Brands (NASDAQ: NWL) today announced its first quarter 2021 financial results.

“2021 is off to a terrific start, as top line increased 21 percent, normalized operating profit doubled and earnings per share tripled year-over-year during the first quarter, building on the momentum from the back half of 2020. Each of our business units and geographic regions delivered significant sales growth, fueled by consumption, as our supply chain teams operated with excellence and successfully managed broad-based demand surges,” said Ravi Saligram, Newell Brands President and CEO. “We are still in the early stages of realizing the full potential of our business and see tremendous opportunity for value creation through focused execution of our strategic priorities, including sustaining top line growth, strengthening our brands through insights and innovation, driving omni-channel prowess, unlocking international potential, and expanding distribution, while serving as a force for good in the world.”

Chris Peterson, Chief Financial Officer and President, Business Operations, said, “Significant out-performance on top line, in combination with productivity gains and operating leverage, drove outstanding results in the first quarter. We made further progress on deleveraging and reducing our cash conversion cycle relative to year-ago levels. Much stronger than anticipated results thus far in 2021 give us confidence to raise our outlook for the full year both on top and bottom lines, despite additional inflationary pressures. We currently forecast core sales growth of 5 to 7 percent and normalized earnings per share of $1.63 to $1.73 for full year 2021.”

First Quarter 2021 Executive Summary

  • Net sales were $2.3 billion, an increase of 21.3 percent compared with the prior year period.
  • Core sales grew 20.9 percent compared with the prior year period. Every business unit and major region increased core sales compared with the prior year period.
  • Reported operating margin was 8.4 percent compared with negative 74.7 percent in the prior year period. Normalized operating margin was 10.1 percent compared with 6.0 percent in the prior year period.
  • Reported diluted earnings per share were $0.21 compared with a $3.02 diluted loss per share in the prior year period.
  • Normalized diluted earnings per share were $0.30 compared with $0.09 per share in the prior year period.
  • The company redeemed the remaining $94 million of its 3.15 percent senior notes that were scheduled to mature in April 2021.
  • The company’s leverage ratio improved to 3.3x at the end of the first quarter from 4.2x in the prior year period and 3.5x at the end of 2020.
  • The company increased its 2021 full year net sales outlook to $9.9 billion to $10.1 billion from its previous range of $9.5 billion to $9.7 billion. The company also raised its 2021 full year outlook for normalized earnings per share to $1.63 to $1.73 from its previous range of $1.55 to $1.65.

First Quarter 2021 Operating Results

Net sales were $2.3 billion, a 21.3 percent increase compared to the prior year period, as core sales growth of 20.9 percent and favorable foreign exchange were partially offset by the impact of business and retail store exits.

Reported gross margin was 31.9 percent compared with 32.7 percent in the prior year period, as inflation, particularly related to resin, transportation and labor, more than offset the benefit from FUEL productivity savings and pricing. Normalized gross margin was 32.2 percent compared with 32.8 percent in the prior year period.

Reported operating income was $192 million compared with operating loss of $1.4 billion in the prior year period, which reflected the impact of impairment charges. Reported operating margin was 8.4 percent compared with a negative 74.7 percent in the prior year period. Normalized operating income was $230 million, or 10.1 percent of sales, compared with $113 million, or 6.0 percent of sales, in the prior year period.

Interest expense was $67 million compared with $63 million in the prior year period.

The company reported a tax provision of $37 million compared with a tax benefit of $204 million in the prior year period, which included discrete tax benefits. Normalized tax expense was $37 million compared with $3 million in the prior year period.

The company reported net income of $89 million, or $0.21 diluted earnings per share, compared with net loss of $1.3 billion, or $3.02 diluted loss per share, in the prior year period.

Normalized net income was $128 million, or $0.30 normalized diluted earnings per share, compared with $39 million, or $0.09 normalized diluted earnings per share, in the prior year period.

An explanation of non-GAAP measures and a reconciliation of these non-GAAP results to comparable GAAP measures are included in the tables attached to this release.

Balance Sheet and Cash Flow

Operating cash outflow was $25 million compared with operating cash flow of $23 million in the prior year period, reflecting working capital increase to support strong net sales growth, which more than offset the year-over-year improvement in the cash conversion cycle.

The company redeemed the remaining $94 million of its 3.15 percent senior notes that were scheduled to mature in April 2021 and repurchased $5 million of its 3.85 percent senior notes due 2023. At the end of the first quarter, Newell Brands had cash and cash equivalents of $682 million and net debt outstanding of $4.8 billion. The company maintained a strong liquidity position, with over $2 billion in available short-term liquidity, including cash on hand. Newell Brands exited the first quarter with a leverage ratio of 3.3x compared to 4.2x in the prior year period and 3.5x at the end of 2020.

Leverage ratio is defined as the ratio of net debt to normalized EBITDA from continuing operations. An explanation of how the leverage ratio is calculated and a related reconciliation, as well as a reconciliation of reported results to normalized results, are included in the tables attached to this release.

First Quarter 2021 Operating Segment Results

The Commercial Solutions segment generated net sales of $471 million compared with $413 million in the prior year period, driven by core sales growth of 12.9 percent and the impact of favorable foreign exchange. Core sales increased in both the Commercial and the Connected Home & Security business units. Reported operating income was $50 million, or 10.6 percent of sales, compared with a loss of $272 million, or negative 65.9 percent of sales, in the prior year period. Normalized operating income was $53 million, or 11.3 percent of sales, versus $51 million, or 12.3 percent of sales, in the prior year period.

The Home Appliances segment generated net sales of $360 million compared with $261 million in the prior year period, reflecting core sales growth of 38.9 percent, partially offset by the impact of unfavorable foreign exchange. Reported operating income was $3 million, or 0.8 percent of sales, compared with a loss of $299 million, or negative 114.6 percent of sales, in the prior year period. Normalized operating income was $8 million, or 2.2 percent of sales, versus operating loss of $9 million, or negative 3.4 percent of sales, in the prior year period.

The Home Solutions segment generated net sales of $504 million compared with $377 million in the prior year period, largely driven by core sales growth of 33.8 percent. Both business units, Food and Home Fragrance, delivered core sales growth. Reported operating income was $61 million, or 12.1 percent of sales, compared with a loss of $301 million, or negative 79.8 percent of sales, in the prior year period. Normalized operating income was $76 million, or 15.1 percent of sales, versus $16 million, or 4.2 percent of sales, in the prior year period.

The Learning & Development segment generated net sales of $617 million compared with $528 million in the prior year period, primarily driven by core sales growth of 17.3 percent. Core sales increased in both Writing and Baby business units. Reported operating income was $110 million, or 17.8 percent of sales, compared with $4 million, or 0.8 percent of sales, in the prior year period. Normalized operating income was $114 million, or 18.5 percent of sales, compared with $86 million, or 16.3 percent of sales, in the prior year period.

The Outdoor & Recreation segment generated net sales of $336 million compared with $307 million in the prior year period, reflecting core sales growth of 7.0 percent and the impact of favorable foreign exchange. Reported operating income was $15 million, or 4.5 percent of sales, compared with a loss of $474 million, or negative 154.4 percent of sales, in the prior year period. Normalized operating income was $20 million, or 6.0 percent of sales, compared with $15 million, or 4.9 percent of sales, in the prior year period.

Outlook for Full Year and Second Quarter 2021

The company updated its full year outlook for 2021 and initiated its second quarter 2021 guidance as follows:

 

 

Previous Full Year 2021 Outlook

 

Updated Full Year 2021 Outlook

Net Sales

 

$9.5 to $9.7 billion

 

$9.9 to $10.1 billion

Core Sales

 

Low single digit growth

 

5% to 7% growth

Normalized Operating Margin

 

30 to 60 bps improvement

to 11.4% to 11.7%

 

30 to 60 bps improvement

to 11.4% to 11.7%

Normalized EPS

 

$1.55 to $1.65

 

$1.63 to $1.73

Operating Cash Flow

 

Approximately $1.0 billion

 

Approximately $1.0 billion

 

                 

Q2 2021 Outlook

Net Sales

                 

$2.5 to $2.58 billion

Core Sales

                 

17% to 20% growth

Normalized Operating Margin

                 

130 to 180 bps improvement

to 11.5% to 12.0%

Normalized EPS

                 

$0.41 to $0.45

The company has presented forward-looking statements regarding normalized operating margin and normalized earnings per share. These non-GAAP financial measures are derived by excluding certain amounts, expenses or income from the corresponding financial measures determined in accordance with GAAP. The determination of the amounts that are excluded from these non-GAAP financial measures is a matter of management judgement and depends upon, among other factors, the nature of the underlying expense or income amounts recognized in a given period. We are unable to present a quantitative reconciliation of forward-looking normalized operating margin or normalized earnings per share to their most directly comparable forward-looking GAAP financial measures because such information is not available, and management cannot reliably predict all of the necessary components of such GAAP measures without unreasonable effort or expense. In addition, we believe such reconciliations would imply a degree of precision that would be confusing or misleading to investors. The unavailable information could have a significant impact on the company’s full-year and second quarter 2021 financial results. These non-GAAP financial measures are preliminary estimates and are subject to risks and uncertainties, including, among others, changes in connection with quarter-end and year-end adjustments. Any variation between the company’s actual results and preliminary financial data set forth above may be material.

Conference Call

Newell Brands’ first quarter 2021 earnings conference call will be held today, April 30, at 10:00 a.m. ET. A link to the webcast is provided under Events & Presentations in the Investors section of the company’s website at www.newellbrands.com. A webcast replay will be made available in the Quarterly Earnings section of the company’s website.

Non-GAAP Financial Measures

This release contains non-GAAP financial measures within the meaning of Regulation G promulgated by the U.S. Securities and Exchange Commission (the “SEC”) and includes a reconciliation of non-GAAP financial measures to the most directly comparable financial measures calculated in accordance with GAAP.

The company uses certain non-GAAP financial measures that are included in this press release and the additional financial information both to explain its results to stockholders and the investment community and in the internal evaluation and management of its businesses. The company’s management believes that these non-GAAP financial measures and the information they provide are useful to investors since these measures (a) permit investors to view the company’s performance and liquidity using the same tools that management uses to evaluate the company’s past performance, reportable business segments, prospects for future performance and liquidity, and (b) determine certain elements of management incentive compensation.

The company’s management believes that core sales provides a more complete understanding of underlying sales trends by providing sales on a consistent basis as it excludes the impacts of acquisitions, planned and completed divestitures, retail store openings and closings, certain market exits, impact of customer returns related to a product recall in Outdoor and Recreation segment, and changes in foreign exchange from year-over-year comparisons. The effect of changes in foreign exchange on reported sales is calculated by applying the prior year average monthly exchange rates to the current year local currency sales amounts (excluding acquisitions and divestitures), with the difference between the 2020 reported sales and constant currency sales presented as the foreign exchange impact increase or decrease in core sales. The company’s management believes that “normalized” gross margin, “normalized” operating income, “normalized” operating margin, “normalized EBITDA,” “normalized EBITDA from continuing operations,” “normalized” net income, “normalized” diluted earnings per share, “normalized” interest and “normalized” tax benefits, which exclude restructuring and restructuring-related expenses and one-time and other events such as costs related to the extinguishment of debt, certain tax benefits and charges, impairment charges, pension settlement charges, divestiture costs, costs related to the acquisition, integration and financing of acquired businesses, amortization of acquisition-related intangible assets, inflationary adjustments, expenses related to certain product recalls and certain other items, are useful because they provide investors with a meaningful perspective on the current underlying performance of the company’s core ongoing operations and liquidity. On a pro forma basis, “normalized” items give effect to the company’s decision not to sell the Commercial, Mapa and Quickie businesses. “Normalized EBITDA from continuing operations” is an ongoing liquidity measure (that excludes non-cash items) and is calculated as pro forma normalized earnings from continuing operations before interest, tax depreciation, amortization and stock-based compensation expense. “Leverage ratio” is a liquidity measure calculated as the ratio of net debt (defined as total debt less cash and cash equivalents) to normalized EBITDA from continuing operations. “Free cash flow productivity” is calculated as the ratio of free cash flow (calculated as net cash provided by operating activities less capital expenditures) to normalized net income, and the company believes that free cash flow productivity is an important indicator of liquidity realized from the company’s core ongoing operations.

The company determines the tax effect of the items excluded from normalized diluted earnings per share by applying the estimated effective rate for the applicable jurisdiction in which the pre-tax items were incurred, and for which realization of the resulting tax benefit, if any, is expected. In certain situations in which an item excluded from normalized results impacts income tax expense, the company utilizes a “with” and “without” approach to determine normalized income tax benefit or expense. The company will also exclude one-time tax expenses related to a change in tax status of certain entities and the loss of GILTI tax credits as a result of utilizing the 50% IRC Section 163(j) limit resulting from the CARES Act to determine normalized income tax benefit.

While the company believes these non-GAAP financial measures are useful in evaluating the company’s performance and liquidity, this information should be considered as supplemental in nature and not as a substitute for or superior to the related financial information prepared in accordance with GAAP. Additionally, these non-GAAP financial measures may differ from similar measures presented by other companies.

About Newell Brands

Newell Brands (NASDAQ: NWL) is a leading global consumer goods company with a strong portfolio of well-known brands, including Rubbermaid®, Paper Mate®, Sharpie®, Dymo®, EXPO®, Parker®, Elmer’s®, Coleman®, Marmot®, Oster®, Sunbeam®, FoodSaver®, Mr. Coffee®, Rubbermaid Commercial Products®, Graco®, Baby Jogger®, NUK®, Calphalon®, Contigo®, First Alert®, Mapa®, Spontex® and Yankee Candle®. Newell Brands is committed to enhancing the lives of consumers around the world with planet friendly, innovative and attractive products that create moments of joy and provide peace of mind.

This press release and additional information about Newell Brands are available on the company’s website, www.newellbrands.com.

Caution Concerning Forward-Looking Statements

Some of the statements in this press release and its exhibits, particularly those anticipating future financial performance, business prospects, growth, operating strategies, the impact of the COVID-19 pandemic and similar matters, are forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. These statements generally can be identified by the use of words or phrases, including, but not limited to, “guidance”, “outlook”, “intend,” “anticipate,” “believe,” “estimate,” “project,” “target,” “plan,” “expect,” “setting up,” “beginning to,” “will,” “should,” “would,” “resume,” “are confident that,” “remain optimistic that,” or similar statements. We caution that forward-looking statements are not guarantees because there are inherent difficulties in predicting future results. Actual results may differ materially from those expressed or implied in the forward-looking statements, including the impairment charges and accounting for income taxes. Important factors that could cause actual results to differ materially from those suggested by the forward-looking statements include, but are not limited to:

  • our ability to manage the demand, supply and operational challenges with the actual or perceived effects of the COVID-19 pandemic;
  • our dependence on the strength of retail, commercial and industrial sectors of the economy in various countries around the world;
  • competition with other manufacturers and distributors of consumer products;
  • major retailers’ strong bargaining power and consolidation of our customers;
  • our ability to improve productivity, reduce complexity and streamline operations;
  • our ability to develop innovative new products, to develop, maintain and strengthen end-user brands and to realize the benefits of increased advertising and promotion spend;
  • our ability to remediate the material weakness in internal control over financial reporting and consistently maintain effective internal control over financial reporting;
  • risks related to our substantial indebtedness, a potential increase in interest rates or changes in our credit ratings;
  • future events that could adversely affect the value of our assets and/or stock price and require additional impairment charges;
  • unexpected costs or expenses associated with divestitures;
  • our ability to effectively execute our turnaround plan;
  • changes in the prices and availability of labor, transportation, raw materials and sourced products, including inflation, and our ability to obtain them in a timely manner;
  • the impact of governmental investigations, inspections, lawsuits, legislative requests or other actions by third parties;
  • the risks inherent to our foreign operations, including currency fluctuations, exchange controls and pricing restrictions;
  • a failure of one of our key information technology systems, networks, processes or related controls or those of our service providers;
  • the impact of U.S. and foreign regulations on our operations, including the impact of tariffs and environmental remediation costs;
  • the potential inability to attract, retain and motivate key employees;
  • the resolution of tax contingencies resulting in additional tax liabilities;
  • product liability, product recalls or related regulatory actions;
  • our ability to protect intellectual property rights;
  • significant increases in funding obligations related to our pension plans; and
  • other factors listed from time to time in our filings with the SEC, including, but not limited to, our Annual Report on Form 10-K and our other SEC filings.

The consolidated condensed financial statements are prepared in conformity with accounting principles generally accepted in the United States (“U.S. GAAP”). Management’s application of U.S. GAAP requires the pervasive use of estimates and assumptions in preparing the unaudited condensed consolidated financial statements. As discussed above, the world is currently experiencing the global COVID-19 pandemic which has required greater use of estimates and assumptions in the preparation of our condensed consolidated financial statements. Although we have made our best estimates based upon current information, the effects of the COVID-19 pandemic on our business may result in future changes to management’s estimates and assumptions, especially if the severity worsens or duration lengthens. Actual results may differ materially from the estimates and assumptions developed by management. If so, the company may be subject to future incremental impairment charges as well as changes to recorded reserves and valuations.

The information contained in this press release and the tables is as of the date indicated. The company assumes no obligation to update any forward-looking statements as a result of new information, future events or developments.

NEWELL BRANDS INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)

(Amounts in millions, except per share data)

 

 

Three Months Ended March 31,

 

 

2021

 

2020

 

% Change

Net sales

 

$

2,288

 

 

$

1,886

 

 

21.3%

Cost of products sold

 

1,557

 

 

1,269

 

 

 

Gross profit

 

731

 

 

617

 

 

18.5%

Selling, general and administrative expenses

 

534

 

 

548

 

 

(2.6)%

Restructuring costs, net

 

5

 

 

2

 

 

 

Impairment of goodwill, intangibles and other assets

 

 

 

1,475

 

 

 

Operating income (loss)

 

192

 

 

(1,408)

 

 

NM

Non-operating expenses:

 

 

 

 

 

 

Interest expense, net

 

67

 

 

63

 

 

 

Other (income) expense, net

 

(1)

 

 

12

 

 

 

Income (loss) before income taxes

 

126

 

 

(1,483)

 

 

NM

Income tax provision (benefit)

 

37

 

 

(204)

 

 

 

Net income (loss)

 

$

89

 

 

$

(1,279)

 

 

NM

 

 

 

 

 

 

 

Weighted average common shares outstanding:

 

 

 

 

 

 

Basic

 

424.9

 

 

423.8

 

 

 

Diluted

 

427.6

 

 

423.8

 

 

 

Earnings (loss) per share:

 

 

 

 

 

 

Basic

 

$

0.21

 

 

$

(3.02)

 

 

 

Diluted

 

$

0.21

 

 

$

(3.02)

 

 

 

 

 

 

 

 

 

 

Dividends per share

 

$

0.23

 

 

$

0.23

 

 

 

 

 

 

 

 

 

 

* NM – NOT MEANINGFUL

 

 

 

 

 

 

NEWELL BRANDS INC.

CONSOLIDATED BALANCE SHEETS (UNAUDITED)

(Amounts in millions)

 

March 31, 2021

 

December 31, 2020

Assets

 

 

 

Current assets

 

 

 

Cash and cash equivalents

$

682

 

 

$

981

 

Accounts receivable, net

1,530

 

 

1,678

 

Inventories

1,901

 

 

1,638

 

Prepaid expenses and other current assets

272

 

 

331

 

Total current assets

4,385

 

 

4,628

 

Property, plant and equipment, net

1,151

 

 

1,176

 

Operating lease assets

513

 

 

530

 

Goodwill

3,525

 

 

3,553

 

Other intangible assets, net

3,506

 

 

3,564

 

Deferred income taxes

843

 

 

838

 

Other assets

417

 

 

411

 

TOTAL ASSETS

$

14,340

 

 

$

14,700

 

Liabilities and stockholders’ equity

 

 

 

Current liabilities

 

 

 

Accounts payable

$

1,501

 

 

$

1,526

 

Accrued compensation

165

 

 

236

 

Other accrued liabilities

1,340

 

 

1,393

 

Short-term debt and current portion of long-term debt

357

 

 

466

 

Total current liabilities

3,363

 

 

3,621

 

Long-term debt

5,135

 

 

5,141

 

Deferred income taxes

438

 

 

414

 

Operating lease liabilities

458

 

 

472

 

Other noncurrent liabilities

1,085

 

 

1,152

 

Total liabilities

10,479

 

 

10,800

 

 

 

 

 

Stockholders’ equity

 

 

 

Total stockholders’ equity attributable to parent

3,836

 

 

3,874

 

Total stockholders’ equity attributable to noncontrolling interests

25

 

 

26

 

Total stockholders’ equity

3,861

 

 

3,900

 

TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY

$

14,340

 

 

$

14,700

 

NEWELL BRANDS INC.

CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)

(Amounts in millions)

 

Three Months Ended March 31,

 

2021

 

2020

Cash flows from operating activities:

 

 

 

Net income (loss)

$

89

 

 

$

(1,279)

 

Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:

 

 

 

Depreciation and amortization

86

 

 

91

 

Impairment of goodwill, intangibles and other assets

 

 

1,475

 

Deferred income taxes

1

 

 

(234)

 

Stock based compensation expense

14

 

 

8

 

Loss on change in fair value of investments

 

 

3

 

Changes in operating accounts:

 

 

 

Accounts receivable

122

 

 

369

 

Inventories

(283)

 

 

(142)

 

Accounts payable

(18)

 

 

(49)

 

Accrued liabilities and other

(36)

 

 

(219)

 

Net cash provided by (used in) operating activities

(25)

 

 

23

 

Cash flows from investing activities:

 

 

 

Capital expenditures

(54)

 

 

(58)

 

Other investing activities, net

 

 

2

 

Net cash used in investing activities

(54)

 

 

(56)

 

Cash flows from financing activities:

 

 

 

Net proceeds from short-term debt

 

 

305

 

Payments on current portion of long-term debt

(94)

 

 

 

Payments on long-term debt

(6)

 

 

(16)

 

Cash dividends

(100)

 

 

(99)

 

Equity compensation activity and other, net

(39)

 

 

(17)

 

Net cash provided by (used in) financing activities

(239)

 

 

173

 

Exchange rate effect on cash, cash equivalents and restricted cash

(14)

 

 

(24)

 

Increase (decrease) in cash, cash equivalents and restricted cash

(332)

 

 

116

 

Cash, cash equivalents and restricted cash at beginning of period

1,021

 

 

371

 

Cash, cash equivalents and restricted cash at end of period

$

689

 

 

$

487

 

Supplemental disclosures:

 

 

 

Restricted cash at beginning of period

$

40

 

 

$

22

 

Restricted cash at end of period

7

 

 

11

 

NEWELL BRANDS INC.

RECONCILIATION OF GAAP AND NON-GAAP INFORMATION (UNAUDITED)

CERTAIN LINE ITEMS

(Amounts in millions, except per share data)

 

 

Three Months Ended March 31, 2021

 

 

GAAP

 

Restructuring

 

Acquisition

 

Transaction

 

Non-GAAP

 

 

Measure

 

and restructuring

 

amortization and

 

costs and

 

Measure

 

 

Reported

 

related costs

[1]

 

impairment

[2]

 

other

[3]

 

Normalized*

Net sales

 

$

2,288

 

 

$

 

 

$

 

 

$

 

 

$

2,288

 

Cost of products sold

 

1,557

 

 

(5)

 

 

 

 

(1)

 

 

1,551

 

Gross profit

 

731

 

 

5

 

 

 

 

1

 

 

737

 

 

 

31.9

%

 

 

 

 

 

 

 

32.2

%

Selling, general and administrative expenses

 

534

 

 

(3)

 

 

(21)

 

 

(3)

 

 

507

 

 

 

23.3

%

 

 

 

 

 

 

 

22.2

%

Restructuring costs, net

 

5

 

 

(5)

 

 

 

 

 

 

 

Impairment of goodwill, intangibles and other assets

 

 

 

 

 

 

 

 

 

 

Operating income

 

192

 

 

13

 

 

21

 

 

4

 

 

230

 

 

 

8.4

%

 

 

 

 

 

 

 

10.1

%

Non-operating (income) expense

 

66

 

 

 

 

 

 

(1)

 

 

65

 

Income before income taxes

 

126

 

 

13

 

 

21

 

 

5

 

 

165

 

Income tax provision (benefit) [4]

 

37

 

 

3

 

 

4

 

 

(7)

 

 

37

 

Net income

 

$

89

 

 

$

10

 

 

$

17

 

 

$

12

 

 

$

128

 

 

 

 

 

 

 

 

 

 

 

 

Diluted earnings per share **

 

$

0.21

 

 

$

0.02

 

 

$

0.04

 

 

$

0.03

 

 

$

0.30

 

*   Normalized results are financial measures that are not in accordance with GAAP and exclude the above normalized adjustments. See below for a discussion of each of these adjustments. 
**   Adjustments and normalized earnings per share are calculated based on diluted weighted average shares of 427.6 million shares for the three months ended March 31, 2021.
  Totals may not add due to rounding.
   

[1]

  Restructuring and restructuring related costs of $13 million.

[2]

  Acquisition amortization costs of $21 million.

[3]

  Other charges of $3 million related to fees for certain legal proceedings and divestiture costs related to completed divestitures and $2 million related to Argentina hyperinflationary adjustment. Includes income tax benefit of $8 million related to difference in effective tax rate.

[4]

  The Company determined the tax effect of the items excluded from normalized results by applying the estimated effective rate for the applicable jurisdiction in which the pre-tax items were incurred, and for which realization of the resulting tax benefit, if any, is expected. In certain situations in which an item excluded from normalized results impacts income tax expense, the Company uses a “with” and “without” approach to determine normalized income tax expense.

NEWELL BRANDS INC.

RECONCILIATION OF GAAP AND NON-GAAP INFORMATION (UNAUDITED)

CERTAIN LINE ITEMS

(Amounts in millions, except per share data)

 

 

Three Months Ended March 31, 2020

 

 

GAAP

 

Restructuring

 

Acquisition

 

Transaction

 

Non-GAAP

 

 

Measure

 

and

restructuring

 

amortization

and

 

costs and

 

Measure

 

 

Reported

 

related costs

[1]

 

impairment

[2]

 

other

[3]

 

Normalized*

Net sales

 

$

1,886

 

 

$

 

 

$

 

 

$

 

 

$

1,886

 

Cost of products sold

 

1,269

 

 

 

 

 

 

(2)

 

 

1,267

 

Gross profit

 

617

 

 

 

 

 

 

2

 

 

619

 

 

 

32.7

%

 

 

 

 

 

 

 

32.8

%

Selling, general and administrative expenses

 

548

 

 

(4)

 

 

(31)

 

 

(7)

 

 

506

 

 

 

29.1

%

 

 

 

 

 

 

 

26.8

%

Restructuring costs, net

 

2

 

 

(2)

 

 

 

 

 

 

 

Impairment of goodwill, intangibles and other assets

 

1,475

 

 

 

 

(1,475)

 

 

 

 

 

Operating income (loss)

 

(1,408)

 

 

6

 

 

1,506

 

 

9

 

 

113

 

 

 

(74.7)

%

 

 

 

 

 

 

 

6.0

%

Non-operating (income) expense

 

75

 

 

 

 

 

 

(4)

 

 

71

 

Income (loss) before income taxes

 

(1,483)

 

 

6

 

 

1,506

 

 

13

 

 

42

 

Income tax provision (benefit) [4]

 

(204)

 

 

1

 

 

229

 

 

(23)

 

 

3

 

Net income (loss)

 

$

(1,279)

 

 

$

5

 

 

$

1,277

 

 

$

36

 

 

$

39

 

 

 

 

 

 

 

 

 

 

 

 

Diluted earnings (loss) per share **

 

$

(3.02)

 

 

$

0.01

 

 

$

3.01

 

 

$

0.08

 

 

$

0.09

 

*   Normalized results are financial measures that are not in accordance with GAAP and exclude the above normalized adjustments. See below for a discussion of each of these adjustments.
**   Adjustments and normalized earnings per share are calculated based on diluted weighted average shares of 424.9 million shares for the three months ended March 31, 2020.
  Totals may not add due to rounding.
   

[1]

  Restructuring and restructuring related costs of $6 million.

[2]

  Acquisition amortization costs of $31 million; impairment charges of approximately $1.5 billion primarily related to goodwill, other intangible assets and operating right of use assets.

[3]

  Other charges of $6 million primarily related to fees for certain legal proceedings; $3 million of loss due to changes in fair market value of investments; $2 million related to Argentina hyperinflationary adjustment; $1 million due to a product recall; divestiture costs of $1 million primarily related to completed divestitures; net gain on disposition of $1 million related to the sale of the Jostens business and $1 million loss on pension settlement. Includes income tax expense of $20 million related to change in tax status of certain entities and $5 million for effects of adopting the Coronavirus Aid, Relief and Economic Security (“CARES”) Act.

[4]

  The Company determined the tax effect of the items excluded from normalized results by applying the estimated effective rate for the applicable jurisdiction in which the pre-tax items were incurred, and for which realization of the resulting tax benefit, if any, is expected. In certain situations in which an item excluded from normalized results impacts income tax expense, the Company uses a “with” and “without” approach to determine normalized income tax expense.

NEWELL BRANDS INC.

RECONCILIATION OF GAAP AND NON-GAAP INFORMATION (UNAUDITED)

FINANCIAL WORKSHEET – SEGMENT REPORTING

(Amounts in millions)

 

Three Months Ended March 31, 2021

 

Three Months Ended March 31, 2020

 

Year over year changes

 

Reported

Reported

 

Normalized

Normalized

 

 

Reported

Reported

 

Normalized

Normalized

 

 

 

 

Normalized Operating

 

Operating

Operating

Excluded

Operating

Operating

 

 

Operating

Operating

Excluded

Operating

Operating

 

Net Sales

 

Income (Loss)

Net Sales

Income

(Loss)

Margin

Items [1]

Income

(Loss)

Margin

 

Net Sales

Income

(Loss)

Margin

Items [2]

Income

(Loss)

Margin

 

$

%

 

$

%

HOME

APPLIANCES

$

360

 

$

3

 

0.8

%

$

5

 

$

8

 

2.2

%

 

$

261

 

$

(299)

 

(114.6)

%

$

290

 

$

(9)

 

(3.4)

%

 

$

99

 

37.9

%

 

$

17

 

NM

COMMERCIAL

SOLUTIONS

471

 

50

 

10.6

%

3

 

53

 

11.3

%

 

413

 

(272)

 

(65.9)

%

323

 

51

 

12.3

%

 

58

 

14.0

%

 

2

 

3.9

%

HOME SOLUTIONS

504

 

61

 

12.1

%

15

 

76

 

15.1

%

 

377

 

(301)

 

(79.8)

%

317

 

16

 

4.2

%

 

127

 

33.7

%

 

60

 

NM

LEARNING AND

DEVELOPMENT

617

 

110

 

17.8

%

4

 

114

 

18.5

%

 

528

 

4

 

0.8

%

82

 

86

 

16.3

%

 

89

 

16.9

%

 

28

 

32.6

%

OUTDOOR AND

RECREATION

336

 

15

 

4.5

%

5

 

20

 

6.0

%

 

307

 

(474)

 

(154.4)

%

489

 

15

 

4.9

%

 

29

 

9.4

%

 

5

 

33.3

%

CORPORATE

 

(47)

 

%

6

 

(41)

 

%

 

 

(66)

 

%

20

 

(46)

 

%

 

 

%

 

5

 

10.9

%

 

$

2,288

 

$

192

 

8.4

%

$

38

 

$

230

 

10.1

%

 

$

1,886

 

$

(1,408)

 

(74.7)

%

$

1,521

 

$

113

 

6.0

%

 

$

402

 

21.3

%

 

$

117

 

NM

[1]

  The three months ended March 31, 2021 excluded items consists of $21 million of acquisition amortization costs; $13 million of restructuring and restructuring-related charges; $3 million of fees for certain legal proceedings and divestiture costs related to completed divestitures and $1 million related to Argentina hyperinflationary adjustment.

[2]

  The three months ended March 31, 2020 excluded items consists of $1.5 billion of impairment charges for goodwill, other intangible assets and operating right of use assets; $31 million of acquisition amortization costs; $6 million of restructuring and restructuring-related charges; $6 million of fees for certain legal proceedings; $1 million for product recall costs; $1 million of transaction-related costs and $1 million related to Argentina hyperinflationary adjustment.
   
  *NM – NOT MEANINGFUL

NEWELL BRANDS INC.

RECONCILIATION OF GAAP AND NON-GAAP INFORMATION (UNAUDITED)

CORE SALES GROWTH BY SEGMENT

 

 

Three Months Ended March 31, 2021

 

 

Net Sales

(REPORTED)

 

Acquisitions,

Divestitures and

Other, Net

[2]

 

Currency

Impact

[3]

 

 

Core Sales

[1] [4]

HOME APPLIANCES

 

37.9

%

 

%

 

1.0

%

 

38.9

%

COMMERCIAL SOLUTIONS

 

14.0

%

 

%

 

(1.1)

%

 

12.9

%

HOME SOLUTIONS

 

33.7

%

 

3.2

%

 

(3.1)

%

 

33.8

%

LEARNING AND DEVELOPMENT

 

16.9

%

 

2.3

%

 

(1.9)

%

 

17.3

%

OUTDOOR AND RECREATION

 

9.4

%

 

%

 

(2.4)

%

 

7.0

%

TOTAL COMPANY

 

21.3

%

 

1.3

%

 

(1.7)

%

 

20.9

%

CORE SALES GROWTH BY GEOGRAPHY

 

 

Three Months Ended March 31, 2021

 

 

Net Sales

(REPORTED)

 

Acquisitions,

Divestitures and

Other, Net

[2]

 

Currency

Impact

[3]

 

 

Core Sales

[1] [4]

NORTH AMERICA

 

17.0

%

 

1.8

%

 

(0.4)

%

 

18.4

%

EUROPE, MIDDLE EAST, AFRICA

 

29.5

%

 

%

 

(10.3)

%

 

19.2

%

LATIN AMERICA

 

23.3

%

 

%

 

13.6

%

 

36.9

%

ASIA PACIFIC

 

43.5

%

 

%

 

(10.2)

%

 

33.3

%

TOTAL COMPANY

 

21.3

%

 

1.3

%

 

(1.7)

%

 

20.9

%

[1]

  “Core Sales” provides a consistent basis for year-over-year comparisons in sales as it excludes the impacts of acquisitions, completed divestitures, retail store openings and closings, changes in foreign currency.

[2]

  Divestitures include the exit of the North American distributorship of Uniball® products, current and prior period net sales from retail store closures (consistent with standard retail practice), disposition of the foamboards business and exit from Home Fragrance fundraising business.

[3]

  “Currency Impact” represents the effect of foreign currency on 2021 reported sales and is calculated by applying the 2020 average monthly exchange rates to the current year local currency sales amounts (excluding acquisitions and divestitures) and comparing to 2021 reported sales.

[4]

  Totals may not add due to rounding.

NEWELL BRANDS INC.

RECONCILIATION OF GAAP AND NON-GAAP INFORMATION (UNAUDITED)

NET DEBT TO NORMALIZED EBITDA FROM CONTINUING OPERATIONS RECONCILIATION

(Amounts in millions)

 

 

March 31, 2021

 

December 31, 2020 [1]

 

March 31, 2020

NET DEBT RECONCILIATION:

 

 

 

 

 

 

Short-term debt and current portion of long-term debt

 

$

357

 

 

$

466

 

 

$

639

 

Long-term debt

 

5,135

 

 

5,141

 

 

5,375

 

Gross debt

 

5,492

 

 

5,607

 

 

6,014

 

Less: Cash and cash equivalents

 

682

 

 

981

 

 

476

 

NET DEBT

 

$

4,810

 

 

$

4,626

 

 

$

5,538

 

 

 

 

 

 

 

 

Income (loss) from continuing operations [2]

 

$

598

 

 

$

(770)

 

 

$

(1,019)

 

Normalized items [2]

 

251

 

 

1,530

 

 

1,700

 

PROFORMA NORMALIZED INCOME (LOSS) FROM CONTINUING OPERATIONS

 

849

 

 

760

 

 

681

 

 

 

 

 

 

 

 

Proforma normalized income tax [2]

 

24

 

 

(10)

 

 

58

 

Interest expense, net [2]

 

278

 

 

274

 

 

286

 

Proforma normalized depreciation and amortization [2] [3]

 

244

 

 

245

 

 

248

 

Stock-based compensation [4]

 

47

 

 

41

 

 

44

 

NORMALIZED EBITDA

 

$

1,442

 

 

$

1,310

 

 

$

1,317

 

 

 

 

 

 

 

 

NET DEBT TO NORMALIZED EBITDA FROM CONTINUING OPERATIONS

LEVERAGE RATIO [5]

 

3.3

x

 

3.5

x

 

4.2

x

[1]

  For the twelve months ended December 31, 2020, refer to “Reconciliation of GAAP and Non-GAAP Information (Unaudited) – Certain Line Items” for the twelve months ended December 31, 2020, on the Company’s Form 8-K furnished on February 12, 2021.

[2]

  For the trailing-twelve months ended March 31, 2021, refer to “Reconciliation of GAAP and Non-GAAP Information (Unaudited) – Certain Line Items” for the three months ended June 30, 2020, September 30, 2020 and December 31, 2020 on the Company’s Forms 8-K furnished on July 31, 2020, October 30, 2020 and February 12, 2021, respectively. For the trailing-twelve months ended March 31, 2020, refer to “Reconciliation of GAAP and Non-GAAP Information (Unaudited) – Certain Line Items” for the three months ended June 30, 2019, September 30, 2019 and December 31, 2019 on the Company’s Forms 8-K furnished on July 31, 2020, October 30, 2020 and February 12, 2021, respectively.

[3]

  For the trailing-twelve months ended March 31, 2021, Proforma normalized depreciation and amortization excludes the following items: (a) acquisition amortization expense of $89 million associated with intangible assets recognized in purchase accounting; (b) $19 million of accelerated depreciation costs associated with restructuring activities. Refer to “Reconciliation of GAAP and Non-GAAP Information (Unaudited) – Certain Line Items” for the three months ended June 30, 2020, September 30, 2020 and December 31, 2020 on the Company’s Forms 8-K furnished on July 31, 2020, October 30, 2020 and February 12, 2021, respectively. For the trailing-twelve months ended March 31, 2020, Proforma normalized depreciation and amortization excludes the following items: (a) acquisition amortization expense of $129 million associated with intangible assets recognized in purchase accounting; (b) $31 million of accelerated depreciation costs associated with restructuring activities; (c) cumulative depreciation and amortization cost of $43 million related to the inclusion of the Commercial Business in continuing operations. Refer to “Reconciliation of GAAP and Non-GAAP Information (Unaudited) – Certain Line Items” for the three months ended June 30, 2019, September 30, 2019 and December 31, 2019 on the Company’s Forms 8-K furnished on July 31, 2020, October 30, 2020 and February 12, 2021, respectively. Proforma Normalized depreciation and amortization excludes from GAAP depreciation and amortization for the twelve months ended December 31, 2020, the following items: (a) acquisition amortization expense of $99 million associated with intangible assets recognized in purchase accounting (b) accelerated depreciation and amortization costs of $13 million associated with restructuring activities. Refer to “Reconciliation of GAAP and Non-GAAP Information (Unaudited) – Certain Line Items” for the twelve months ended December 31, 2020 for further information.

[4]

  Represents non-cash expense associated with stock-based compensation from continuing operations.

[5]

  The Net Debt to Normalized EBITDA from continuing operations ratio is defined as Net Debt divided by Normalized EBITDA from continuing operations. The Company’s debt has certain financial covenants such as debt to equity ratio and interest coverage ratio; however the Net Debt to Normalized EBITDA from continuing operations leverage ratio is used by management as a liquidity measure and is not prescribed in the Company’s debt covenants.

NEWELL BRANDS INC.

RECONCILIATION OF GAAP AND NON-GAAP INFORMATION (UNAUDITED)

CORE SALES OUTLOOK

 

Three Months Ending

June 30, 2021

 

Twelve Months Ending

December 31, 2021

Estimated net sales change (GAAP)

18%

to

22%

 

5%

to

8%

Deduct: Estimated currency impact [1] and divestitures [2], net

~ 1%

to

~ 2%

 

~ 0%

to

~ 1%

Core sales change (NON-GAAP)

17%

to

20%

 

5%

to

7%

[1]

  “Currency Impact” represents the effect of foreign currency on 2021 reported sales and is calculated by applying the 2020 average monthly exchange rates to the current year local currency sales amounts (excluding acquisitions and divestitures) and comparing to 2021 reported sales.

[2]

  Divestitures include the exit of the North American distributorship of Uniball® products, current and prior period net sales from retail store closures (consistent with standard retail practice), disposition of the foamboards business and exit from Home Fragrance fundraising business.

 

Investor Contact:

Sofya Tsinis

VP, Investor Relations

+1 (201) 610-6901

[email protected]

Media Contact:

Beth Stellato

VP, Corporate Communications, Events & Philanthropy

+1 (470) 580-1086

[email protected]

KEYWORDS: United States North America Georgia

INDUSTRY KEYWORDS: Retail Other Consumer Consumer Other Retail Home Goods Office Products

MEDIA:

Logo
Logo

First National Corporation Reports First Quarter 2021 Financial Results

STRASBURG, Va., April 30, 2021 (GLOBE NEWSWIRE) — First National Corporation (the “Company” or “First National”) (NASDAQ: FXNC), the bank holding company of First Bank (the “Bank”), reported unaudited consolidated net income of $2.4 million, or $0.50 per diluted share, for the first quarter of 2021, which resulted in return on average assets of 1.00% and return on average equity of 11.53%. This compares to net income of $1.7 million, or $0.34 per diluted share, and return on average assets of 0.85% and return on average equity of 8.72% for the first quarter of 2020.

During the first quarter of 2021, the Company entered into an agreement to acquire The Bank of Fincastle (the “Merger”) and incurred merger related expenses totaling $405 thousand. The merger related expenses were comprised of legal and professional fees and had a $0.07 per share impact to basic and diluted earnings per share for the period. 

Key highlights of the first quarter of 2021 are as follows. Comparisons are to the corresponding period in the prior year unless otherwise stated:

  Merger related expenses totaled $405 thousand, which impacted earnings per share by $0.07
  Return on average assets of 1.00%
  Return on average equity of 11.53%
  Efficiency ratio of 64.53%
  Net interest income increased $486 thousand, or 7%
  Wealth management revenue increased $118 thousand, or 22%
  Tangible book value increased 9% to $17.65 per share

“During the first quarter, our banking company exceeded $1.0 billion in assets, announced an agreement to acquire The Bank of Fincastle, absorbed merger related expenses, and delivered excellent financial results,” said Scott Harvard, president and chief executive officer of First National. Harvard continued, “The entire team continues to adopt more efficient delivery processes resulting in the highest levels of productivity in our history. During the quarter, customers continued to take advantage of Bank’s digital delivery channels as the number of accounts opened online increased 88% when compared to same period of 2020 and represented 10% of all accounts opened in the quarter. Growth in net interest income combined with diligent expense management also positively contributed to profitability.”

COVID-19 PANDEMIC UPDATE

Operations

During the first quarter, the Bank continued to follow its Pandemic Plan that strives to protect the health of its employees and customers, while continuing to deliver essential banking services. In response to vaccinations that continued to be provided to thousands of people in our market areas, and the decrease in the number of COVID-19 cases in our communities, the Bank entered phase two of its plan in late March 2021 after operating in phase one since early December 2020. After operating for almost four months primarily through branch drive throughs, ATMs, and mobile and internet banking platforms, lobbies re-opened for walk-in customers to conduct their banking business.

Paycheck Protection Program

The Bank continued to participate as a lender in the U.S. Small Business Administration’s (“SBA”) Paycheck Protection Program (“PPP”) to support local small businesses and non-profit organizations by providing forgivable loans. During the second and third quarters of 2020, the Bank originated $76.6 million of PPP loans, received $2.5 million of loan fees from the SBA, and incurred $535 thousand of loan origination costs. The PPP stopped accepting applications in August of 2020. The loan fees continue to be accreted into earnings evenly over the life of the loans, net of loan origination costs, through interest and fees on loans. PPP loans originated in 2020 totaled $46.5 at March 31, 2021, and 99% of the PPP loan balances are scheduled to mature in the second quarter of 2022.

Congress revived the PPP as part of the COVID-19 relief bill that was signed into law on December 27, 2020. The Bank began participating again as a lender in the PPP in January of 2021. During the first quarter of 2021, the Bank originated $19.8 million of PPP loans and incurred $51 thousand of loan origination costs. First Bank expects to receive $1.1 million of loan fees from the SBA as a result of the loan originations. Like the PPP loans originated in 2020, loan fees received will be accreted into earnings evenly over the life of the loans, net of loan origination costs, through interest and fees on loans. PPP loans that were originated in 2021 totaled $19.8 million at March 31, 2021, and 100% of the PPP loan balances are scheduled to mature in the first quarter of 2026. 

Asset Quality Impact

The pandemic has negatively impacted the financial condition of certain loan customers. The Bank expects customers in certain sectors of its commercial real estate loan portfolio, including retail shopping, lodging and leisure, may experience elevated financial pressure in future periods. Those sectors comprised 5%, 4% and 2% of the loan portfolio, respectively, excluding PPP loans, at March 31, 2021. The Bank also expects that loans in those same sectors of its commercial and industrial loan portfolio may also experience financial pressure in future periods. The magnitude of the potential decline in the Bank’s loan quality in future periods will likely depend on the duration of the pandemic and the extent that the Bank’s customers experience business interruptions.

Loan Modifications

In response to the unknown impact of the pandemic on the economy and its customers, the Bank created and implemented a loan payment deferral program for individual and business customers beginning in the first quarter of 2020, which provided them the opportunity to defer monthly payments for 90 days. By June 30, 2020, loans participating in the program reached $182.6 million. The majority of these loans resumed regular payments during the second half of 2020 after their deferral periods ended. There were no loans remaining in the program at March 31, 2021.

During the fourth quarter of 2020, the Bank modified terms of certain loans for customers that continued to be negatively impacted by the pandemic by lowering borrower’s loan payments with interest only payments for periods ranging between 6 and 24 months. Modified loans totaled $14.3 million at March 31, 2021, with $14.2 million in the Bank’s commercial real estate loan portfolio and $83 thousand in the commercial and industrial loans portfolio. The loans were comprised of $12.8 million in the lodging sector and $1.5 million in the leisure sector.

Capital

The Company issued $5.0 million of subordinated debt in June 2020 as a result of its risk management program and capital planning. The purpose of the issuance was primarily to further strengthen holding company liquidity and to remain a source of strength for the Bank in the event of a severe economic downturn. The Company may also use the proceeds of the issuance for general corporate purposes, including the potential repayment of the Company’s subordinated debt that was issued in 2015 and became callable on a quarterly basis beginning January 1, 2021. The Company issued the debt with a 5.50% fixed-to-floating rate subordinated note due 2030 to an institutional investor and was structured to qualify as Tier 2 capital under bank regulatory guidelines.

After being suspended for most of 2020, the Company’s stock repurchase plan ended on December 31, 2020. The Company has not authorized another stock repurchase plan due to the continued uncertainty and potential impact of the pandemic on the economy and the Bank’s customers. The Company continued to pay cash dividends on common stock of $0.11 per share throughout 2020, and in February 2021, it declared a quarterly cash dividend on common stock of $0.12 per share, which was a 9% increase.

BALANCE SHEET

Total assets of First National increased $211.7 million, or 26%, to $1.0 billion at March 31, 2021, compared to $816.4 million at March 31, 2020. Interest-bearing deposits in banks increased $146.8 million, total securities increased $27.2 million, or 18%, and loans, net of the allowance for loan losses, increased $54.4 million, or 9%. These increases were partially offset by a $19 thousand decrease in cash and due from banks. The growth in the loan portfolio included PPP loans that totaled $66.2 million at the end of the first quarter. 

Total liabilities increased $204.3 million, or 28%, to $942.2 million at March 31, 2021, compared to $737.9 million one year ago. The increase in total liabilities was primarily attributable to significant growth in deposits. Total deposits increased $195.4 million, or 27%, to $916.1 million. Noninterest-bearing demand deposits increased $94.6 million, or 48%, savings and interest-bearing demand deposits increased $118.5 million, or 29%, while time deposits decreased $17.6 million, or 15%. The origination of PPP loans during the last twelve-month period contributed to the deposit growth as many customers deposited proceeds of the loans in their deposit accounts at the Bank. Although proceeds from PPP loan originations contributed to the increase in deposits, the Bank also experienced a significant amount of deposit growth that was not related to proceeds from PPP loan originations.

Shareholders’ equity increased $7.4 million, or 9%, to $85.9 million at March 31, 2021, compared to one year ago, primarily from an increase in retained earnings. The Bank was considered well-capitalized at March 31, 2021.

PERFORMANCE ANALYSIS OF THE THREE-MONTH PERIOD

Net interest income increased $486 thousand, or 7%, to $7.5 million for the first quarter of 2021, compared to the same period of 2020. The increase resulted from a $559 thousand, or 49%, decrease in total interest expense, which was partially offset by a $73 thousand decrease in total interest and dividend income. The net interest margin decreased 50 basis points to 3.27%. The decrease in the net interest margin was offset by growth in average earning assets of $182.0 million, or 24%, and resulted in an increase in net interest income. 

The decrease in interest expense was primarily a result of a $599 thousand, or 62%, decrease in interest expense on deposits, which was attributable to reduced interest rates paid on deposits. The impact of an $88.6 million, or 17% increase in average interest-bearing deposits was offset by a 51-basis point decrease in the cost of interest-bearing deposits. A 42-basis point reduction of the cost of interest-bearing checking accounts and a 96-basis point reduction of the cost of money market accounts made the largest contributions to the decrease in interest expense. 

The decrease in total interest and dividend income resulted from an 85-basis point decrease in the yield on earning assets, which was partially offset by a $182.0 million, or 24%, increase in average earning assets. The decrease in the yield on earning assets resulted from a 46-basis point decrease in the yield on loans and a 120-basis point decrease in the yield on interest-bearing deposits in banks. The loan yield was negatively impacted by PPP loans earning a 1.00% interest rate. Additionally, the mix of earning assets had an unfavorable impact on the yield on average earning assets as lower yielding interest-bearing deposits in banks increased from 5% to 15% of average earning assets.

Noninterest income increased $44 thousand, or 2%, to $2.1 million compared to the same period of 2020. Service charges on deposits decreased $239 thousand, or 35%, which was offset by ATM and check card fees that increased $82 thousand, or 16%, wealth management fees that increased $118 thousand, or 22%, and fees for other customer services that increased $79 thousand, or 38%. The decrease in service charges on deposits resulted from a reduction in overdraft fee income, which the Bank believes may have resulted from the significant increase in deposit balances over the last twelve months. Wealth management fees increased from a higher amount of assets under management, and fees for other customer services increased primarily from fee revenue on brokered mortgage loans sold to the secondary market. 

Noninterest expense increased $506 thousand, or 8%, to $6.7 million, compared to the same period one year ago. The increase was primarily attributable to a $458 thousand increase in legal and professional fees, which included merger related expenses of $405 thousand.

ASSET QUALITY/LOAN LOSS PROVISION

There was no provision for loan losses for the first quarter of 2021, which was attributable to net recoveries of loans previously charged off and no significant changes to the general and specific reserve components of the allowance for loan losses. Net recoveries totaled $1 thousand for the quarter compared to net charge-offs of $250 thousand for the same period one year ago. The allowance for loan losses totaled $7.5 million, or 1.17% of total loans at March 31, 2021. Excluding PPP loans, the allowance for loan losses totaled 1.30% of total loans. Provision for loan losses totaled $900 thousand for the same period of 2020 and the allowance for loan losses totaled $5.6 million, or 0.96% of total loans at March 31, 2020.

Loans 30 to 89 days past due and accruing totaled $906 thousand, or 0.14% of total loans at March 31, 2021 compared to $2.9 million, or 0.50% of total loans one year ago. Accruing substandard loans totaled $1.3 million at March 31, 2021 and $4.4 million at March 31, 2020. Nonperforming assets consisted only of non-accrual loans and totaled $6.8 million, or 0.66% of total assets at March 31. 2021, compared to $1.5 million, or 0.19% of total assets one year ago.

FORWARD-LOOKING STATEMENTS

Certain information contained in this discussion may include “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements relate to the Company’s future operations and are generally identified by phrases such as “the Company expects,” “the Company believes” or words of similar import. Although the Company believes that its expectations with respect to the forward-looking statements are based upon reliable assumptions within the bounds of its knowledge of its business and operations, there can be no assurance that actual results, performance or achievements of the Company will not differ materially from any future results, performance or achievements expressed or implied by such forward-looking statements. Forward-looking statements involve a number of risks and uncertainties, including the rapidly changing uncertainties related to the COVID-19 pandemic and its potential adverse effect on the economy, our employees and customers, and our financial performance. For details on other factors that could affect expectations, see the risk factors and other cautionary language included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2020, and other filings with the Securities and Exchange Commission.

ABOUT FIRST NATIONAL CORPORATION

First National Corporation (NASDAQ: FXNC) is the parent company and bank holding company of First Bank, a community bank that first opened for business in 1907 in Strasburg, Virginia. The Bank offers loan and deposit products and services through its website, www.fbvirginia.com, its mobile banking platform, a network of ATMs located throughout its market area, one loan production office, a customer service center in a retirement community, and 14 bank branch office locations located throughout the Shenandoah Valley, the central regions of Virginia and in the city of Richmond. In addition to providing traditional banking services, the Bank operates a wealth management division under the name First Bank Wealth Management. First Bank also owns First Bank Financial Services, Inc., which invests in entities that provide investment services and title insurance.

CONTACTS

Scott C. Harvard M. Shane Bell
President and CEO Executive Vice President and CFO
(540) 465-9121 (540) 465-9121
[email protected] [email protected]



FIRST NATIONAL CORPORATION

Quarterly Performance Summary

(in thousands, except share and per share data)

    (unaudited)  
    For the Quarter Ended  
    March 31,     December 31,     September 30,     June 30,     March 31,  
    2021     2020     2020     2020     2020  
Income Statement                                        
Interest income                                        
Interest and fees on loans   $ 7,143     $ 7,310     $ 7,568     $ 7,416     $ 7,203  
Interest on deposits in banks     33       31       25       16       118  
Interest on securities                                        
Taxable interest     717       567       575       636       670  
Tax-exempt interest     180       163       152       151       151  
Dividends     22       24       23       26       26  
Total interest income   $ 8,095     $ 8,095     $ 8,343     $ 8,245     $ 8,168  
Interest expense                                        
Interest on deposits   $ 363     $ 410     $ 541     $ 676     $ 962  
Interest on subordinated debt     154       160       160       91       90  
Interest on junior subordinated debt     66       68       68       67       90  
Total interest expense   $ 583     $ 638     $ 769     $ 834     $ 1,142  
Net interest income   $ 7,512     $ 7,457     $ 7,574     $ 7,411     $ 7,026  
Provision for (recovery of) loan losses           (200 )     1,500       800       900  
Net interest income after provision for (recovery of) loan losses   $ 7,512     $ 7,657     $ 6,074     $ 6,611     $ 6,126  
Noninterest income                                        
Service charges on deposit accounts   $ 442     $ 553     $ 446     $ 348     $ 681  
ATM and check card fees     601       576       669       550       519  
Wealth management fees     643       598       573       512       525  
Fees for other customer services     286       216       323       237       207  
Income from bank owned life insurance     113       124       131       99       115  
Net gains on securities     37       2       38              
Net gains on sale of loans     7       10       3       26       31  
Other operating income     14       73       18       1       21  
Total noninterest income   $ 2,143     $ 2,152     $ 2,201     $ 1,773     $ 2,099  
Noninterest expense                                        
Salaries and employee benefits   $ 3,555     $ 3,212     $ 3,498     $ 3,022     $ 3,589  
Occupancy     447       422       433       409       402  
Equipment     431       440       439       418       410  
Marketing     106       112       63       74       106  
Supplies     88       90       112       103       89  
Legal and professional fees     737       310       262       301       279  
ATM and check card expense     231       253       259       223       245  
FDIC assessment     69       105       52       60       30  
Bank franchise tax     168       161       162       161       153  
Data processing expense     204       196       191       188       184  
Amortization expense     14       24       33       42       52  
Other operating expense     600       569       631       612       605  
Total noninterest expense   $ 6,650     $ 5,894     $ 6,135     $ 5,613     $ 6,144  
Income before income taxes   $ 3,005     $ 3,915     $ 2,140     $ 2,771     $ 2,081  
Income tax expense     569       759       386       528       376  
Net income   $ 2,436     $ 3,156     $ 1,754     $ 2,243     $ 1,705  



FIRST NATIONAL CORPORATION

Quarterly Performance Summary

(in thousands, except share and per share data)

    (unaudited)  
    For the Quarter Ended  
    March 31,     December 31,     September 30,     June 30,     March 31,  
    2021     2020     2020     2020     2020  
Common Share and Per Common Share Data                                        
Net income, basic   $ 0.50     $ 0.65     $ 0.36     $ 0.46     $ 0.34  
Weighted average shares, basic     4,863,823       4,858,288       4,854,144       4,849,719       4,950,887  
Net income, diluted   $ 0.50     $ 0.65     $ 0.36     $ 0.46     $ 0.34  
Weighted average shares, diluted     4,872,097       4,861,208       4,854,649       4,849,719       4,955,970  
Shares outstanding at period end     4,868,462       4,860,399       4,858,217       4,852,187       4,849,692  
Tangible book value at period end   $ 17.65     $ 17.47     $ 16.92     $ 16.63     $ 16.17  
Cash dividends   $ 0.12     $ 0.11     $ 0.11     $ 0.11     $ 0.11  
                                         
Key Performance Ratios                                        
Return on average assets     1.00 %     1.31 %     0.74 %     1.00 %     0.85 %
Return on average equity     11.53 %     15.03 %     8.52 %     11.30 %     8.72 %
Net interest margin     3.27 %     3.30 %     3.41 %     3.59 %     3.77 %
Efficiency ratio (1)     64.53 %     61.00 %     62.35 %     60.34 %     66.50 %
                                         
Average Balances                                        
Average assets   $ 988,324     $ 954,810     $ 944,390     $ 899,301     $ 806,609  
Average earning assets     937,199       904,511       889,127       836,741       755,173  
Average shareholders’ equity     85,708       83,545       81,894       79,845       78,659  
                                         
Asset Quality                                        
Loan charge-offs   $ 66     $ 165     $ 115     $ 176     $ 328  
Loan recoveries     67       73       96       88       78  
Net charge-offs (recoveries)     (1 )     92       19       88       250  
Non-accrual loans     6,814       6,714       6,974       1,480       1,522  
Other real estate owned, net                              
Nonperforming assets     6,814       6,714       6,974       1,480       1,522  
Loans 30 to 89 days past due, accruing     906       996       885       1,094       2,901  
Loans over 90 days past due, accruing           302       6       1       86  
Troubled debt restructurings, accruing                       4,313        
Special mention loans                 510       2,034       6,058  
Substandard loans, accruing     1,343       1,394       3,804       8,616       4,368  
                                         
Capital Ratios (2)                                        
Total capital   $ 94,044     $ 91,243     $ 89,155     $ 88,109     $ 86,849  
Tier 1 capital     86,717       84,032       81,883       81,813       81,265  
Common equity tier 1 capital     86,717       84,032       81,883       81,813       81,265  
Total capital to risk-weighted assets     16.05 %     15.82 %     15.34 %     15.20 %     14.98 %
Tier 1 capital to risk-weighted assets     14.80 %     14.57 %     14.09 %     14.11 %     14.02 %
Common equity tier 1 capital to risk-weighted assets     14.80 %     14.57 %     14.09 %     14.11 %     14.02 %
Leverage ratio     8.78 %     8.80 %     8.67 %     9.08 %     10.08 %



FIRST NATIONAL CORPORATION

Quarterly Performance Summary

(in thousands, except share and per share data)

    (unaudited)  
    For the Quarter Ended  
    March 31,     December 31,     September 30,     June 30,     March 31,  
    2021     2020     2020     2020     2020  
Balance Sheet                                        
Cash and due from banks   $ 11,940     $ 13,115     $ 13,349     $ 17,717     $ 30,551  
Interest-bearing deposits in banks     164,322       114,182       108,857       90,562       17,539  
Securities available for sale, at fair value     159,742       140,225       117,132       123,193       128,660  
Securities held to maturity, at amortized cost     13,424       14,234       15,101       16,211       17,086  
Restricted securities, at cost     1,631       1,875       1,848       1,848       1,848  
Loans held for sale           245             170       621  
Loans, net of allowance for loan losses     630,716       622,429       640,591       645,220       576,283  
Premises and equipment, net     19,087       19,319       19,548       19,792       19,619  
Accrued interest receivable     2,609       2,717       3,156       3,863       2,124  
Bank owned life insurance     18,029       17,916       17,792       17,661       17,562  
Core deposit intangibles, net     5       19       43       76       118  
Other assets     6,625       4,656       5,316       5,777       4,401  
Total assets   $ 1,028,130     $ 950,932     $ 942,733     $ 942,090     $ 816,412  
                                         
Noninterest-bearing demand deposits   $ 292,280     $ 263,229     $ 256,733     $ 253,974     $ 197,662  
Savings and interest-bearing demand deposits     526,012       479,035       480,017       470,764       407,555  
Time deposits     97,765       100,197       101,645       114,277       115,410  
Total deposits   $ 916,057     $ 842,461     $ 838,395     $ 839,015     $ 720,627  
Subordinated debt     9,992       9,991       9,987       9,982       4,987  
Junior subordinated debt     9,279       9,279       9,279       9,279       9,279  
Accrued interest payable and other liabilities     6,876       4,285       2,816       3,026       3,001  
Total liabilities   $ 942,204     $ 866,016     $ 860,477     $ 861,302     $ 737,894  
                                         
Preferred stock   $     $     $     $     $  
Common stock     6,086       6,075       6,073       6,065       6,062  
Surplus     6,214       6,151       6,081       5,967       5,899  
Retained earnings     71,144       69,292       66,670       65,451       63,741  
Accumulated other comprehensive income, net     2,482       3,398       3,432       3,305       2,816  
Total shareholders’ equity   $ 85,926     $ 84,916     $ 82,256     $ 80,788     $ 78,518  
Total liabilities and shareholders’ equity   $ 1,028,130     $ 950,932     $ 942,733     $ 942,090     $ 816,412  
                                         
Loan Data                                        
Mortgage loans on real estate:                                        
Construction and land development   $ 25,720     $ 27,328     $ 27,472     $ 31,981     $ 40,279  
Secured by farmland     507       521       533       872       888  
Secured by 1-4 family residential     236,870       235,814       234,198       234,188       230,980  
Other real estate loans     248,357       246,362       249,786       247,623       240,486  
Loans to farmers (except those secured by real estate)     436       637       1,120       711       1,221  
Commercial and industrial loans (except those secured by real estate)     117,109       109,201       124,157       123,995       54,287  
Consumer installment loans     5,684       6,458       7,378       8,401       9,505  
Deposit overdrafts     112       143       194       170       238  
All other loans     3,407       3,450       3,530       3,575       3,983  
Total loans   $ 638,202     $ 629,914     $ 648,368     $ 651,516     $ 581,867  
Allowance for loan losses     (7,486 )     (7,485 )     (7,777 )     (6,296 )     (5,584 )
Loans, net   $ 630,716     $ 622,429     $ 640,591     $ 645,220     $ 576,283  



FIRST NATIONAL CORPORATION

Quarterly Performance Summary

(in thousands, except share and per share data)

    (unaudited)  
    For the Quarter Ended  
    March 31,     December 31,     September 30,     June 30,     March 31,  
    2021     2020     2020     2020     2020  
Reconciliation of Tax-Equivalent Net Interest Income                                        
GAAP measures:                                        
Interest income – loans   $ 7,143     $ 7,310     $ 7,568     $ 7,416     $ 7,203  
Interest income – investments and other     952       785       775       829       965  
Interest expense – deposits     (363 )     (410 )     (541 )     (676 )     (962 )
Interest expense – subordinated debt     (154 )     (160 )     (160 )     (91 )     (90 )
Interest expense – junior subordinated debt     (66 )     (68 )     (68 )     (67 )     (90 )
Total net interest income   $ 7,512     $ 7,457     $ 7,574     $ 7,411     $ 7,026  
Non-GAAP measures:                                        
Tax benefit realized on non-taxable interest income – loans   $ 8     $ 8     $ 8     $ 8     $ 10  
Tax benefit realized on non-taxable interest income – municipal securities     48       43       41       40       40  
Total tax benefit realized on non-taxable interest income   $ 56     $ 51     $ 49     $ 48     $ 50  
Total tax-equivalent net interest income   $ 7,568     $ 7,508     $ 7,623     $ 7,459     $ 7,076  

(1) The efficiency ratio is computed by dividing noninterest expense excluding other real estate owned income/expense, amortization of intangibles, gains and losses on disposal of premises and equipment, and merger related expenses by the sum of net interest income on a tax-equivalent basis and noninterest income, excluding gains and losses on sales of securities. Tax-equivalent net interest income is calculated by adding the tax benefit realized from interest income that is nontaxable to total interest income then subtracting total interest expense. The tax rate utilized in calculating the tax benefit is 21%. See the tables above for tax-equivalent net interest income and reconciliations of net interest income to tax-equivalent net interest income. The efficiency ratio is a non-GAAP financial measure that management believes provides investors with important information regarding operational efficiency. Such information is not prepared in accordance with U.S. generally accepted accounting principles (GAAP) and should not be construed as such. Management believes; however, such financial information is meaningful to the reader in understanding operational performance, but cautions that such information not be viewed as a substitute for GAAP.

(2) All capital ratios reported are for First Bank.

 



Castle Biosciences Supports American Academy of Dermatology’s “Skin Cancer, Take a Hike!™” Steps Challenge for Skin Cancer Awareness Month

Castle Biosciences Supports American Academy of Dermatology’s “Skin Cancer, Take a Hike!Steps Challenge for Skin Cancer Awareness Month

The month-long fundraising event invites the public to help log 9,500 miles in honor of the approximately 9,500 people diagnosed with skin cancer every day

FRIENDSWOOD, Texas–(BUSINESS WIRE)–
Castle Biosciences, Inc. (Nasdaq: CSTL), a skin cancer diagnostics company providing personalized genomic information to improve cancer treatment decisions, today announced its national sponsorship of the American Academy of Dermatology’s (AAD) “Skin Cancer, Take a Hike!™”steps challenge for Skin Cancer Awareness Month.

“Skin Cancer, Take a Hike!” is a participant-driven fundraising event that has raised $1.5 million since its inaugural 2014 hike. By educating the public about skin cancer prevention and early detection, the AAD and its partners like Castle aim to drive sun-safety behaviors that can reduce skin cancer and ultimately save lives. “Skin Cancer, Take a Hike!” proceeds are dedicated to reducing the incidence of skin cancer through public education and access to life-saving programs and services, including free skin cancer screenings, permanent shade structures where children learn and play, and sunscreen dispensers in public areas, such as parks and pools.

At this year’s virtual event, held throughout May for Skin Cancer Awareness Month, hundreds of participants across the country will complete 9,500 miles in honor of the approximately 9,500 people diagnosed with skin cancer every day.

“We greatly appreciate the support of Castle Biosciences in our efforts to help the public prevent skin cancer and detect it early, when it’s most treatable,” says dermatologist Kenneth J. Tomecki, M.D., FAAD, president of the AAD. “Skin cancer is the most common cancer in the U.S., and nearly 20 Americans die from melanoma, the deadliest form of skin cancer, every day. By working together to raise awareness through ‘Skin Cancer, Take a Hike!’, we want to remind the public that they can protect their skin from the sun and reduce their risk of skin cancer by seeking shade, wearing protective clothing — including a wide-brimmed hat and sunglasses with UV protection — and applying a broad-spectrum sunscreen with an SPF of 30 or higher to all skin not covered by clothing.”

“Skin Cancer, Take a Hike!” is part of the AAD’s SPOT Skin Cancer™ initiative to reduce skin cancer mortality and incidence through public awareness, community outreach programs and services, and advocacy that promotes the prevention, detection and treatment of skin cancer. Thanks to the campaign’s dedicated volunteers and donors, SPOT Skin Cancer has provided more than 2.8 million free skin cancer screenings and awarded 432 shade structure grants, which provide shade for nearly 3.5 million individuals daily.

“Among the viable techniques to mitigate harm caused by skin cancer, the importance of prevention and early detection cannot be overstated,” said Derek Maetzold, president and chief executive officer of Castle Biosciences. “Castle’s primary focus is to improve the lives of patients with skin cancer. In addition to our suite of prognostic and diagnostic tests, we recognize that reducing sun exposure, wearing sunscreen and UV-blocking clothing and getting screened for cancer are critical for improving health outcomes. Often, the largest barriers to wide uptake of those measures include insufficient awareness and insufficient financial allocation to their distribution—two barriers that we are proud to confront alongside the AAD.”

About the AAD

Headquartered in Rosemont, Ill., the American Academy of Dermatology, founded in 1938, is the largest, most influential, and most representative of all dermatologic associations. With a membership of more than 20,000 physicians worldwide, the AAD is committed to: advancing the diagnosis and medical, surgical and cosmetic treatment of the skin, hair and nails; advocating high standards in clinical practice, education, and research in dermatology; and supporting and enhancing patient care for a lifetime of healthier skin, hair and nails. For more information, contact the AAD at (888) 462-DERM (3376) or aad.org. Follow the AAD on Facebook (American Academy of Dermatology), Twitter (@AADskin), Instagram (@AADskin1), or YouTube (AcademyofDermatology).

About Castle Biosciences

Castle Biosciences (Nasdaq: CSTL) is a commercial-stage dermatologic cancer company focused on providing physicians and their patients with personalized, clinically actionable genomic information to make more accurate treatment decisions. The Company currently offers tests for patients with cutaneous melanoma (DecisionDx®-Melanoma, DecisionDx®-CMSeq), cutaneous squamous cell carcinoma (DecisionDx®-SCC), suspicious pigmented lesions (DecisionDx® DiffDx™-Melanoma) and uveal melanoma (DecisionDx®-UM, DecisionDx®-PRAME and DecisionDx®-UMSeq). For more information about Castle’s gene expression profile tests, visit www.CastleTestInfo.com. Castle also has active research and development programs for tests in other dermatologic diseases with high clinical need. Castle Biosciences is based in Friendswood, Texas (Houston), and has laboratory operations in Phoenix, Arizona. For more information, visit www.CastleBiosciences.com.

DecisionDx-Melanoma, DecisionDx-CMSeq, DecisionDx-SCC, DecisionDx DiffDx-Melanoma, DecisionDx-UM, DecisionDx-PRAME and DecisionDx-UMSeq are trademarks of Castle Biosciences, Inc.

Media and Investor Contact:

Camilla Zuckero

281-906-3868

[email protected]

KEYWORDS: United States North America Illinois Texas

INDUSTRY KEYWORDS: Oncology Philanthropy Health Genetics Fund Raising Pharmaceutical Biotechnology

MEDIA:

NewAge Europe on Record Pace for Growth, Experiencing Tremendous Surge in Brand Partners and Customer Growth and Attendance at Virtual Events

DENVER, April 30, 2021 (GLOBE NEWSWIRE) — NewAge, Inc. (Nasdaq: NBEV), the Colorado-based organic and healthy products company intending to become the world’s leading social selling and distribution company, today announced record net revenue growth in Europe, record numbers of new Brand Partners joining the Company, and record attendance at their virtual events, with more than 18,000 current and prospective Brand Partners participating in their most recent outing.

NewAge, Inc. that was formed with the merger of ARIIX, Morinda, and four other E-commerce companies in November 2020, has been experiencing accelerated organic growth building on the success of the merger and the excitement associated with it. NewAge Europe, under the leadership of Region President Cameron Bott has been experiencing triple-digit organic growth closing out 2020 and has been carrying forward the success into 2021.

Tens of thousands of new Brand Partners have joined the company just in the past few months in the key Western European focus markets of France, Italy, Spain, Belgium, and the UK. Additionally, tens of thousands of new customers have become recent subscribers to NewAge’s portfolio of healthy products.   

NewAge™ recently created high-end online interactive technology platforms that now enable the Company’s virtual events to be broadcast real-time across 12 different languages. NewAge also set a new record with more than 18,000 attendees at the live-streamed events throughout Europe encompassing 21 countries with a total social media reach of almost 200,000 people.

Cameron Bott, President of Europe commented, “We are seeing the incredible growth in Europe that we experienced in 2020 now just accelerate in 2021 with all the new Brand Partners joining us. Our digital and social media marketing and selling activities are expanding exponentially and having a tremendous impact on our revenue growth. The pandemic has effected how we conduct business everywhere, but we have rapidly responded and adjusted our model and as a result are using the change as an opportunity and a growth catalyst.”

NewAge recently presented its first ever combined awards program at the most recent virtual event since converging the companies. Hundreds of NewAge Brand Partners were recognized for their achievements and contributions in the immersive online experience. Using virtual reality and AR, the event featured many executives on stage via holograms to present the awards, including Group President Mark Wilson, and CEO Brent Willis.

About New Age, Inc.

NewAge is a purpose-driven firm intending to become the world’s leading social selling and distribution company. Colorado-based NewAge commercializes a portfolio of organic and healthy products worldwide through primarily a direct route-to-market system. The company competes in three major category platforms including health and wellness, inner and outer beauty, and nutrition and weight control — leading a network of more than 400,000 exclusive independent distributors and brand partners around the world.

The company operates the websites newage.com, noninewage.com, ariix.com, mavie.com, thelimucompany.com and zennoa.com websites.  

For investor inquiries about NewAge, please contact:

NewAge Investor Relations:

Riley Timmer
Vice President, Investor Relations
Tel: 1-801-870-8685
[email protected]

For media inquiries about NewAge, please contact:

NewAge Public Relations:

Mindy Eardley
PR/Communications Manager
Tel: 1-801-573-4818
[email protected]



Pitney Bowes Announces First Quarter 2021 Financial Results

Pitney Bowes Announces First Quarter 2021 Financial Results

STAMFORD, Conn.–(BUSINESS WIRE)–
Pitney Bowes Inc. (NYSE: PBI), a global technology company that provides commerce solutions in the areas of ecommerce, shipping, mailing and financial services, today announced its financial results for the first quarter 2021.

“We delivered a solid start to the year, with every business making a meaningful contribution to our first quarter results,” said Marc B. Lautenbach, President and CEO, Pitney Bowes. “Revenue continued to demonstrate strong growth, every business improved its EBIT performance from prior year, and we strengthened our balance sheet. As we enter the final chapter of our transformation, we are well-positioned to reach our ultimate goal of achieving improved profitable revenue growth.”

First Quarter 2021

  • Revenue of $915 million, growth of 15 percent on a reported basis and 14 percent excluding the impact of currency
  • GAAP EPS of ($0.18), which includes a loss related to debt refinancing
  • Adjusted EPS of $0.07
  • EPS reflects a $0.02 tax benefit associated with an affiliate reorganization.
  • GAAP cash from operations of $66 million; free cash flow net use of $1 million.
  • The Company reduced debt by $126 million from year-end 2020 and took several actions to refine its capital structure which reduced near-term refinancing risk, improved pricing of its Term Loan B and extended the duration of maturities across its capital structure.
  • Global Ecommerce grew revenue 41 percent on a reported basis and 40 percent excluding the impact of currency; EBIT margins and EBITDA margins improved over prior year.
  • Presort Services grew revenue, EBIT margins and EBITDA margins over prior year.
  • SendTech EBIT margins and EBITDA margins improved over prior year, which is the second consecutive quarter of EBIT and EBITDA year-over-year dollar growth.

Earnings per share results are summarized in the table below:

 

First Quarter*

 

2021

 

2020

GAAP EPS

($0.18)

 

($1.22)

Discontinued operations

(0.02)

 

(0.06)

GAAP EPS from continuing operations

($0.16)

 

($1.28)

Restructuring charges

0.01

 

0.02

Goodwill impairment charge

 

1.15

Loss on debt refinancing

0.22

 

0.16

Adjusted EPS

$0.07

 

$0.05

* The sum of the earnings per share may not equal the totals due to rounding.

Business Segment Reporting

Global Ecommerce facilitates domestic retail ecommerce shipping solutions, including delivery, returns and fulfillment, and global cross-border ecommerce transactions.

Presort Services provides sortation services to qualify large volumes of First Class Mail, Marketing Mail, Marketing Mail Flats and Bound Printed Matter for postal workshare discounts.

Sending Technology Solutions offers physical and digital mailing and shipping technology solutions, financing, services, supplies and other applications for small and medium businesses to help simplify and save on the sending, tracking and receiving of letters, parcels and flats.

Global Ecommerce

 

First Quarter

($ millions)

2021

2020

% Change

Reported

% Change

Ex Currency

Revenue

$413

 

$292

 

41%

 

40%

EBITDA

($8)

 

($11)

 

28%

 

 

EBIT

($26)

 

($29)

 

11%

 

 

Revenue benefited primarily from growth in volumes across all services. EBIT and EBITDA benefited from improved Cross Border and Digital Delivery Service margins, partly offset by higher costs in Domestic Parcel Services. EBIT and EBITDA improved through the quarter with March being EBITDA positive.

Presort Services

 

First Quarter

($ millions)

2021

2020

% Change

Reported

% Change

Ex Currency

Revenue

$143

 

$141

 

2%

 

2%

EBITDA

$27

 

$23

 

13%

 

 

EBIT

$19

 

$16

 

21%

 

 

Revenue benefited primarily from growth in Marketing Mail. EBIT and EBITDA margins improved over prior year and were the highest margins in five quarters.

SendTech Solutions

 

First Quarter

($ millions)

2021

2020

% Change

Reported

% Change

Ex Currency

Revenue

$359

 

$363

 

(1%)

 

(3%)

EBITDA

$122

 

$116

 

6%

 

 

EBIT

$114

 

$107

 

7%

 

 

Revenue benefited from growth in equipment sales, business services and rentals, partly offset by declines in financing, supplies and support services. EBIT margin improved from prior year and was the highest margin in three quarters.

Full Year 2021 Expectations

The Company’s full year 2021 expectations are consistent with what was communicated last quarter. The Company expects annual revenue to grow in the low-to-mid single digit range, making 2021 the fifth consecutive year of constant currency growth. The Company expects adjusted EPS to grow over prior year driven largely by improvement in Global Ecommerce, which is expected to be EBITDA positive for the full year. The Company also expects lower free cash flow primarily due to specific items that benefited 2020 and are not expected to continue at the same level in 2021.

Conference Call and Webcast

Management of Pitney Bowes will discuss the Company’s results in a broadcast over the Internet today at 8:00 a.m. EST. Instructions for listening to the earnings results via the Web are available on the Investor Relations page of the Company’s web site at www.pitneybowes.com.

About Pitney Bowes

Pitney Bowes (NYSE:PBI) is a global technology company providing commerce solutions that power billions of transactions. Clients around the world, including 90 percent of the Fortune 500, rely on the accuracy and precision delivered by Pitney Bowes solutions, analytics, and APIs in the areas of ecommerce fulfillment, shipping and returns; cross-border ecommerce; office mailing and shipping; presort services; and financing. For 100 years, Pitney Bowes has been innovating and delivering technologies that remove the complexity of getting commerce transactions precisely right. For additional information, visit www.pitneybowes.com.

Use of Non-GAAP Measures

The Company’s financial results are reported in accordance with generally accepted accounting principles (GAAP); however, in its disclosures the Company uses certain non-GAAP measures, such as adjusted earnings before interest and taxes (EBIT), adjusted earnings before interest, taxes, depreciation and amortization (EBITDA), adjusted earnings per share (EPS), revenue growth on a constant currency basis and free cash flow.

The Company reports measures such as adjusted EBIT, adjusted EBITDA and adjusted EPS to exclude the impact of items like discontinued operations, restructuring charges, gains, losses and costs related to acquisitions and dispositions, asset impairment charges, goodwill impairment charges and other unusual or one-time items. While these are actual Company income or expenses, they can mask underlying trends associated with its business. Such items are often inconsistent in amount and frequency and as such, the non-GAAP measures provide investors greater insight into the underlying operating trends of the business.

In addition, revenue growth is presented on a constant currency basis to exclude the impact of changes in foreign currency exchange rates since the prior period under comparison. Constant currency is calculated by converting the current period non-U.S. dollar denominated revenue using the prior year’s exchange rate for the comparable quarter. We believe that excluding the impacts of currency exchange rates provides investors a better understanding of the underlying revenue performance. A reconciliation of reported revenue to constant currency revenue can be found in the attached financial schedules.

The Company reports free cash flow in order to provide investors insight into the amount of cash that management could have available for other discretionary uses. Free cash flow adjusts GAAP cash from operations for cash flows of discontinued operations, capital expenditures, restructuring payments, changes in customer deposits held at the Pitney Bowes Bank, transaction costs and other special items. A reconciliation of GAAP cash from operations to free cash flow can be found in the attached financial schedules.

Segment EBIT is the primary measure of profitability and operational performance at the segment level. Segment EBIT is determined by deducting from segment revenue the related costs and expenses attributable to the segment. Segment EBIT excludes interest, taxes, general corporate expenses not allocated to a particular business segment, restructuring charges and goodwill and asset impairments, which are recognized on a consolidated basis. The Company also provides segment EBITDA, which further excludes depreciation and amortization expense for the segment, as an additional useful measure of segment profitability and operational performance. A reconciliation of segment EBIT and EBITDA to net income can be found in the attached financial schedules.

Pitney Bowes has provided a quantitative reconciliation to GAAP in supplemental schedules. This information can be found at the Company’s web site www.pb.com/investorrelations.

This document contains “forward-looking statements” about the Company’s expected or potential future business and financial performance. Forward-looking statements include, but are not limited to, statements about its future revenue and earnings guidance and other statements about future events or conditions. Forward-looking statements are not guarantees of future performance and involve risks and uncertainties that could cause actual results to differ materially from those projected. These risks and uncertainties include the severity, magnitude and duration of the Covid-19 pandemic (Covid-19), including governments’ responses to Covid-19, the efficacy and availability of vaccines, its continuing impact on our operations, employees, the availability and cost of labor and transportation, global supply chain and demand across our and our clients’ businesses as well as any deterioration or instability in global macroeconomic conditions. Other factors, which could cause future financial performance to differ materially from expectations, and which may also be exacerbated by Covid-19 or a negative change in the economy, include, without limitation: declining physical mail volumes; changes in postal regulations or operations, or the financial health of posts, in the U.S. or other major markets or significant changes to the broader postal or shipping industry; the loss of, or significant changes in, our contractual relationships with the United States Postal Service (USPS) or USPS’ performance under those contracts; our ability to continue to grow and manage volumes, gain additional economies of scale and improve profitability within our Global Ecommerce and Presort Services segments; changes in labor and transportation availability and costs; third-party suppliers’ ability to provide products and services required by us and our clients; competitive factors, including pricing pressures, technological developments and the introduction of new products and services by competitors; the loss of some of our larger clients in our Global Ecommerce and Presort Services segments; expenses and potential impacts resulting from a breach of security, including cyber-attacks or other comparable events; our success at managing customer credit risk; and other factors as more fully outlined in the Company’s 2020 Form 10-K Annual Report and other reports filed with the Securities and Exchange Commission. Pitney Bowes assumes no obligation to update any forward-looking statements contained in this document as a result of new information, events or developments.

Note: Consolidated statements of income; revenue, EBIT and EBITDA by business segment; and reconciliations of GAAP to non-GAAP measures for the three months ended March 31, 2021 and 2020, and consolidated balance sheets at March 31, 2021 and December 31, 2020 are attached.

 
Pitney Bowes Inc.
Consolidated Statements of Loss
(Unaudited; in thousands, except per share amounts)
 
Three months ended March 31,

 

2021

 

 

2020

 

Revenue:
Business services

$

570,454

 

$

444,379

 

Support services

 

118,697

 

 

122,015

 

Financing

 

77,812

 

 

89,078

 

Equipment sales

 

86,803

 

 

76,273

 

Supplies

 

42,224

 

 

45,709

 

Rentals

 

19,207

 

 

18,814

 

Total revenue

 

915,197

 

 

796,268

 

 
Costs and expenses:
Cost of business services

 

499,534

 

 

374,665

 

Cost of support services

 

36,717

 

 

39,760

 

Financing interest expense

 

11,886

 

 

12,489

 

Cost of equipment sales

 

61,840

 

 

57,359

 

Cost of supplies

 

11,211

 

 

12,240

 

Cost of rentals

 

6,447

 

 

6,378

 

Selling, general and administrative

 

238,102

 

 

248,633

 

Research and development

 

11,316

 

 

12,116

 

Restructuring charges

 

2,889

 

 

3,817

 

Goodwill impairment

 

 

 

198,169

 

Interest expense, net

 

25,158

 

 

25,883

 

Other components of net pension and postretirement expense (income)

 

350

 

 

(151

)

Other expense, net

 

51,394

 

 

33,487

 

Total costs and expenses

 

956,844

 

 

1,024,845

 

 
Loss from continuing operations before taxes

 

(41,647

)

 

(228,577

)

Benefit for income taxes

 

(13,992

)

 

(10,030

)

Loss from continuing operations

 

(27,655

)

 

(218,547

)

(Loss) income from discontinued operations, net of tax

 

(3,886

)

 

10,064

 

Net loss

$

(31,541

)

$

(208,483

)

 
Basic loss per share (1):
Continuing operations

$

(0.16

)

$

(1.28

)

Discontinued operations

 

(0.02

)

 

0.06

 

Net loss

$

(0.18

)

$

(1.22

)

 
Diluted loss per share (1):
Continuing operations

$

(0.16

)

$

(1.28

)

Discontinued operations

 

(0.02

)

 

0.06

 

Net loss

$

(0.18

)

$

(1.22

)

 
Weighted-average shares used in diluted earnings per share

 

172,856

 

 

170,912

 

 

(1

)

The sum of the earnings per share amounts may not equal the totals due to rounding.
 
 
Pitney Bowes Inc.
Consolidated Balance Sheets
(Unaudited; in thousands)
 
Assets March 31,
2021
December 31,
2020
Current assets:
Cash and cash equivalents

$

680,727

 

$

921,450

 

Short-term investments

 

16,200

 

 

18,974

 

Accounts and other receivables, net

 

327,755

 

 

389,240

 

Short-term finance receivables, net

 

551,061

 

 

568,050

 

Inventories

 

63,680

 

 

65,845

 

Current income taxes

 

44,288

 

 

23,219

 

Other current assets and prepayments

 

124,394

 

 

120,145

 

Total current assets

 

1,808,105

 

 

2,106,923

 

Property, plant and equipment, net

 

405,226

 

 

391,280

 

Rental property and equipment, net

 

37,708

 

 

38,435

 

Long-term finance receivables, net

 

597,012

 

 

605,292

 

Goodwill

 

1,144,064

 

 

1,152,285

 

Intangible assets, net

 

152,265

 

 

159,839

 

Operating lease assets

 

196,843

 

 

201,916

 

Noncurrent income taxes

 

68,732

 

 

72,653

 

Other assets

 

531,226

 

 

491,514

 

Total assets

$

4,941,181

 

$

5,220,137

 

 
Liabilities and stockholders’ equity
Current liabilities:
Accounts payable and accrued liabilities

$

820,286

 

$

880,616

 

Customer deposits at Pitney Bowes Bank

 

589,406

 

 

617,200

 

Current operating lease liabilities

 

39,587

 

 

39,182

 

Current portion of long-term debt

 

19,972

 

 

216,032

 

Advance billings

 

118,166

 

 

114,550

 

Current income taxes

 

6,839

 

 

2,880

 

Total current liabilities

 

1,594,256

 

 

1,870,460

 

Long-term debt

 

2,418,885

 

 

2,348,361

 

Deferred taxes on income

 

282,192

 

 

279,451

 

Tax uncertainties and other income tax liabilities

 

37,936

 

 

38,163

 

Noncurrent operating lease liabilities

 

174,798

 

 

180,292

 

Other noncurrent liabilities

 

413,951

 

 

437,015

 

Total liabilities

 

4,922,018

 

 

5,153,742

 

 
Stockholders’ equity:
Common stock

 

323,338

 

 

323,338

 

Additional paid-in-capital

 

15,269

 

 

68,502

 

Retained earnings

 

5,161,029

 

 

5,201,195

 

Accumulated other comprehensive loss

 

(847,538

)

 

(839,131

)

Treasury stock, at cost

 

(4,632,935

)

 

(4,687,509

)

Total stockholders’ equity

 

19,163

 

 

66,395

 

Total liabilities and stockholders’ equity

$

4,941,181

 

$

5,220,137

 

 
 
Pitney Bowes Inc.
Business Segment Revenue
(Unaudited; in thousands)
 
Three months ended March 31,

 

2021

 

2020

% Change

 
Global Ecommerce

$

413,086

$

292,323

41%

 
Presort Services

 

143,126

 

140,720

2%

 
Sending Technology Solutions

 

358,985

 

363,225

(1%)

 
Total revenue – GAAP

 

915,197

 

796,268

15%

 
Currency impact on revenue

 

(8,803)

 

 
Revenue, at constant currency

$

906,394

$

796,268

14%

 
 
Pitney Bowes Inc.
Business Segment EBIT & EBITDA
(Unaudited; in thousands)
 
Three months ended March 31,

2021

2020

% change
EBIT (1) D&A EBITDA EBIT (1) D&A EBITDA EBIT EBITDA
 
Global Ecommerce

$

(26,376)

$

18,176

$

(8,200)

$

(29,475)

$

18,065

$

(11,410)

11%

28%

 
Presort Services

 

19,051

 

7,499

 

26,550

 

15,695

 

7,774

 

23,469

21%

13%

 
Sending Technology Solutions

 

114,470

 

7,604

 

122,074

 

106,562

 

9,039

 

115,601

7%

6%

 
Segment total

$

107,145

$

33,279

 

140,424

$

92,782

$

34,878

 

127,660

15%

10%

 
Reconciliation of Segment EBITDA to Net Income:
Segment depreciation and amortization

 

(33,279)

 

(34,878)

Unallocated corporate expenses

 

(57,465)

 

(43,722)

Restructuring charges

 

(2,889)

 

(3,817)

Interest, net

 

(37,044)

 

(38,372)

Goodwill impairment

 

 

(198,169)

Loss on debt refinancing

 

(51,394)

 

(36,987)

Transaction costs

 

 

(292)

Benefit for income taxes

 

13,992

 

10,030

Loss from continuing operations

 

(27,655)

 

(218,547)

(Loss) income from discontinued operations, net of tax

 

(3,886)

 

10,064

Net loss

$

(31,541)

$

(208,483)

 
(1) Segment EBIT excludes interest, taxes, general corporate expenses, restructuring charges, and other items that are not allocated to a particular business segment.
 
Pitney Bowes Inc.
Reconciliation of Reported Consolidated Results to Adjusted Results
(Unaudited; in thousands, except per share amounts)
 
Three months ended March 31,

 

2021

 

2020

 
Reconciliation of reported net loss to adjusted EBIT and EBITDA
Net loss

$

(31,541)

$

(208,483)

Loss (income) from discontinued operations, net of tax

 

3,886

 

(10,064)

Benefit for income taxes

 

(13,992)

 

(10,030)

Loss from continuing operations before taxes

 

(41,647)

 

(228,577)

Restructuring charges

 

2,889

 

3,817

Goodwill impairment

 

 

198,169

Loss on debt refinancing

 

51,394

 

36,987

Transaction costs

 

 

292

Adjusted net income before tax

 

12,636

 

10,688

Interest, net

 

37,044

 

38,372

Adjusted EBIT

 

49,680

 

49,060

Depreciation and amortization

 

39,594

 

40,719

Adjusted EBITDA

$

89,274

$

89,779

 
Reconciliation of reported diluted loss per share to adjusted diluted earnings per share
Diluted loss per share

$

(0.18)

$

(1.22)

Loss (income) from discontinued operations, net of tax

 

0.02

 

(0.06)

Restructuring charges

 

0.01

 

0.02

Goodwill impairment

 

 

1.15

Loss on debt refinancing

 

0.22

 

0.16

Adjusted diluted earnings per share (1)

$

0.07

$

0.05

 
Reconciliation of reported net cash from operating activities to free cash flow
Net cash provided by (used in) operating activities

$

65,924

$

(67,355)

Net cash used in operating activities – discontinued operations

 

 

37,805

Capital expenditures

 

(43,328)

 

(25,778)

Restructuring payments

 

3,955

 

6,047

Change in customer deposits at PB Bank

 

(27,794)

 

(888)

Transaction costs paid

 

 

1,740

Free cash flow

$

(1,243)

$

(48,429)

 
(1) The sum of the earnings per share amounts may not equal the totals due to rounding.

 

Editorial –

Bill Hughes

Chief Communications Officer

203/351-6785

Financial –

Adam David

VP, Investor Relations

203/351-7175

KEYWORDS: Connecticut United States North America

INDUSTRY KEYWORDS: Software Technology Transport Logistics/Supply Chain Management

MEDIA:

Logo
Logo

Middleby Schedules First Quarter Earnings Release and Conference Call

Middleby Schedules First Quarter Earnings Release and Conference Call

ELGIN, Ill.–(BUSINESS WIRE)–
The Middleby Corporation (NASDAQ: MIDD) today announced it will release 2021 first quarter earnings on Thursday, May 6 before the market opens. The company has scheduled a conference call to discuss the results at noon Eastern/11 a.m. Central time on May 6. The conference call is accessible through the Investor Relations section of the company website at www.middleby.com. If website access is not available, the call can be joined by dialing (888) 391-6937 or (315) 625-3077 and entering conference code 1355164#.

ABOUT THE MIDDLEBY CORPORATION

The Middleby Corporation is a global leader in the foodservice equipment industry. The company develops, manufactures, markets and services a broad line of equipment used in the commercial foodservice, food processing, and residential kitchen equipment industries. The company’s leading equipment brands serving the commercial foodservice industry include Anets®, APW Wyott®, Bakers Pride®, Beech®, BKI®, Blodgett®, Blodgett Combi®, Bloomfield®, Britannia®, Carter-Hoffmann®, Celfrost®, Concordia®, CookTek®, Crown®, CTX®, Desmon®, Deutsche Beverage®, Doyon®, Eswood®, EVO®, Firex®, Follett®, frifri®, Giga®, Globe®, Goldstein®, Holman®, Houno®, IMC®, Induc®, Ink Kegs®, Inline Filling Systems®, Jade®, JoeTap®, Josper®, L2F®, Lang®, Lincat®, MagiKitch’n®, Market Forge®, Marsal®, Meheen®, Middleby Marshall®, MPC®, Nieco®, Nu-Vu®, PerfectFry®, Pitco®, QualServ®, RAM®, Southbend®, Ss Brewtech®, Star®, Starline®, Sveba Dahlen®, Synesso®, Tank®, Taylor®, Thor®, Toastmaster®, TurboChef®, Ultrafryer®, Varimixer®, Wells® Wild Goose® and Wunder-Bar®. The company’s leading equipment brands serving the food processing industry include Alkar®, Armor Inox®, Auto-Bake®, Baker Thermal Solutions®, Burford®, Cozzini®, CV-Tek ®, Danfotech®, Deutsche Process®, Drake®, Glimek®, Hinds-Bock®, Maurer-Atmos®, MP Equipment®, Pacproinc®, RapidPak®, Scanico®, Spooner Vicars®, Stewart Systems®, Thurne® and Ve.Ma.C.®. The company’s leading equipment brands serving the residential kitchen industry include AGA®, AGA Cookshop®, Brava®, EVO®, La Cornue®, Leisure Sinks®, Lynx®, Marvel®, Mercury®, Rangemaster®, Rayburn®, Redfyre®, Sedona®, Stanley®, TurboChef®, U-Line® and Viking®.

For more information about The Middleby Corporation and the company brands, please visit www.middleby.com.

Darcy Bretz, Director of Corporate Communications, (847) 429-7756

KEYWORDS: Illinois United States North America

INDUSTRY KEYWORDS: Other Manufacturing Other Retail Supermarket Manufacturing Home Goods Restaurant/Bar Food/Beverage Retail Supply Chain Management

MEDIA:

Lippert Acquired Markdorf, Germany-Based Schaudt With Newly-Formed German Subsidiary

Lippert Acquired Markdorf, Germany-Based Schaudt With Newly-Formed German Subsidiary

ELKHART, Ind.–(BUSINESS WIRE)–
LCI Industries (NYSE: LCII), through its wholly-owned subsidiary, Lippert Components, Inc. (“Lippert”) which supplies a broad array of highly engineered components for the leading original equipment manufacturers (“OEMs”) in the recreation and transportation product markets, and the related aftermarkets of those industries, today announced that its new wholly-owned German subsidiary, LCI Industries GmbH, acquired 100% of the shares of Schaudt GmbH Elektrotechnik & Apparatebau (“Schaudt”), a leading supplier of electronic controls and energy management systems for the European Caravan Industry. Located in Markdorf, Germany, Schaudt has been one of the leading suppliers to the recreational vehicle market in Germany and throughout Europe for over 40 years.

The formation of LCI Industries GmbH and the subsequent acquisition of Schaudt is part of Lippert’s larger European strategy to be closer to its key German customers and to have local contacts within the country. Schaudt’s facilities in Markdorf are expected to become the hub for Lippert’s German operations and are planned to eventually offer services for all Lippert brands and products for the German market. Schaudt will also partner with Lippert Technologies, Lippert’s North American electronics and technology manufacturer based out of Detroit, Michigan, to offer globally-aligned technology solutions that will help to set new global standards for these products.

Schaudt has proven over many years to be a leading partner to key European caravan manufacturers, delivering innovative power supply and booster systems, and controlling solutions and indicator panels that are setting new standards within the industry. Schaudt’s engineers work closely with their customers to develop customized solutions to work toward solving their challenges. Their philosophy is to always think ahead, making their solutions easier, safer and more compatible, focusing on the most user-friendly design possible. Most importantly, Schaudt is focusing on providing a full range of power supply and control products, linking all of these systems and making them completely expandable.

“We are excited to welcome Schaudt to the Lippert family, reaching a long-term goal of having operations within Germany,” said Jason Lippert, President and CEO of Lippert. He continued, “I am very impressed with Schaudt’s team; they have excellent leadership and their culture fits perfectly within the Lippert family. Lippert’s goal has always been to be the leading global supplier to the RV Industry, and Schaudt helps develop that global footprint with key product and service offerings in the largest RV market in Europe.”

“Schaudt’s excellent reputation for customer service and their great customer relationships were key to this partnership,” said Jim Menefee, Group President of Lippert Europe. “At Lippert, we understand the importance of offering our European customers localized services in their native language, all while maintaining quick reaction times and being as flexible as possible. This acquisition will no doubt strengthen our ability to deliver all of these aspects of business. To that point, we are excited that Barbara Härle and Armin Steinmetz are staying on as directors, and we have the utmost trust in them leading this newly-acquired German subsidiary,” he continued.

“We are happy to start on this new journey with the Lippert family, a true global player in our industry with the same goals as we have; to serve our customers with reliability and to have 100% focus on the customer,” said Barbara Härle, Managing Director of Schaudt. She continued, “We also appreciate their sense of responsibility for their team members, their communities and the future generations to come.”

Armin Steinmetz, Managing Director for Schaudt, also commented: “The rate at which recreational vehicles are adapting electronics is rapidly increasing and becoming more complex by the day. Having a global strategy with this new partnership will be a big benefit for customers and end users alike.”

About LCI Industries

LCI Industries, through its wholly-owned subsidiary, Lippert, supplies, domestically and internationally, a broad array of highly engineered components for the leading OEMs in the recreation and transportation product markets, consisting primarily of recreational vehicles and adjacent industries, including buses; trailers used to haul boats, livestock, equipment, and other cargo; trucks; boats; trains; manufactured homes; and modular housing. The Company also supplies engineered components to the related aftermarkets of these industries, primarily by selling to retail dealers, wholesale distributors, and service centers. Lippert’s products include steel chassis and related components; axles and suspension solutions; slide-out mechanisms and solutions; thermoformed bath, kitchen, and other products; vinyl, aluminum, and frameless windows; manual, electric, and hydraulic stabilizer and leveling systems; entry, luggage, patio, and ramp doors; furniture and mattresses; electric and manual entry steps; awnings and awning accessories; towing products; truck accessories; electronic components; and other accessories. Additional information about Lippert and its products can be found at www.lci1.com.

Forward-Looking Statements

This press release contains certain “forward-looking statements” with respect to our financial condition, results of operations, business strategies, operating efficiencies or synergies, competitive position, growth opportunities, acquisitions, plans and objectives of management, markets for the Company’s common stock, the impact of legal proceedings, and other matters. Statements in this press release that are not historical facts are “forward-looking statements” for the purpose of the safe harbor provided by Section 21E of the Securities Exchange Act of 1934, as amended, and Section 27A of the Securities Act of 1933, as amended, and involve a number of risks and uncertainties.

Forward-looking statements, including, without limitation, those relating to our future business prospects, net sales, expenses and income (loss), capital expenditures, tax rate, cash flow, financial condition, liquidity, covenant compliance, retail and wholesale demand, integration of acquisitions, R&D investments, and industry trends, whenever they occur in this press release are necessarily estimates reflecting the best judgment of the Company’s senior management at the time such statements were made. There are a number of factors, many of which are beyond the Company’s control, which could cause actual results and events to differ materially from those described in the forward-looking statements. These factors include, in addition to other matters described in this press release, the impacts of COVID-19, or other future pandemics, on the global economy and on the Company’s customers, suppliers, employees, business and cash flows, pricing pressures due to domestic and foreign competition, costs and availability of, and tariffs on, raw materials (particularly steel and aluminum) and other components, seasonality and cyclicality in the industries to which we sell our products, availability of credit for financing the retail and wholesale purchase of products for which we sell our components, inventory levels of retail dealers and manufacturers, availability of transportation for products for which we sell our components, the financial condition of our customers, the financial condition of retail dealers of products for which we sell our components, retention and concentration of significant customers, the costs, pace of and successful integration of acquisitions and other growth initiatives, availability and costs of production facilities and labor, team member benefits, team member retention, realization and impact of expansion plans, efficiency improvements and cost reductions, the disruption of business resulting from natural disasters or other unforeseen events, the successful entry into new markets, the costs of compliance with environmental laws, laws of foreign jurisdictions in which we operate, other operational and financial risks related to conducting business internationally, and increased governmental regulation and oversight, information technology performance and security, the ability to protect intellectual property, warranty and product liability claims or product recalls, interest rates, oil and gasoline prices and availability, the impact of international, national and regional economic conditions and consumer confidence on the retail sale of products for which we sell our components, and other risks and uncertainties discussed more fully under the caption “Risk Factors” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2020, and in the Company’s subsequent filings with the Securities and Exchange Commission. Readers of this press release are cautioned not to place undue reliance on these forward-looking statements, since there can be no assurance that these forward-looking statements will prove to be accurate. The Company disclaims any obligation or undertaking to update forward-looking statements to reflect circumstances or events that occur after the date the forward-looking statements are made, except as required by law.

Contact: Brian M. Hall, CFO

Phone: (574) 535-1125

E Mail: [email protected]

KEYWORDS: Indiana Germany Europe United States North America

INDUSTRY KEYWORDS: Automotive Manufacturing Manufacturing Lodging Travel Women Other Transport Maritime Men General Automotive Transport Aftermarket Family Vacation Automotive Consumer

MEDIA: